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Abstract 
 
Lyophilization has been used to improve the quality of pharmaceutical proteins when 
sufficient stability in the aqueous state cannot be achieved. However, due to inherent 
challenges in both the freeze-drying process and formulation of proteins for freeze 
drying, efficient delivery of drug products with uniformly improved stability is not trivial. 
The overall objective of this work was to investigate freeze-dried protein quality 
attributes affected by stress factors arising from process and formulation.  
The natural variation in ice nucleation temperature (Tn) necessitates the control of ice 
nucleation to ensure uniformity in product quality across a batch. Further, it is less well 
understood what critical factors are attributed to protein stability after ice nucleation. 
Freezing parameters including Tn, shelf ramp rate and isothermal hold after ice nucleation 
were studied. Controlling ice nucleation at a higher temperature was found to not only 
improve average protein stability, but also improved batch uniformity on in-process 
stability. Additionally, the findings suggested that a long residence time in the freeze-
concentrate, at a temperature above Tg’ of the formulation can result in significant protein 
aggregation.  
Further, to address whether there is a shelf location-dependent mass flow resistance (Rp) 
during primary drying, differences in Rp between center and edge vials were estimated 
Rui Fang – University of Connecticut, 2018 
from correlations that were established between Tn, SSA of the freeze-dried solid, and Rp. 
The findings provide insights into developing methods to accurately measure Rp in 
individual vials.    
Lastly, formulation variables can greatly impact stability during process and storage. 
Storage below Tg slows molecular mobility of the system on a pharmaceutical relevant 
timescale and reduces degradation. However, physical and chemical degradation still 
occurs below Tg; other motions, such as internal dynamics within a protein molecule, 
have been proposed to exist in solid proteins and potentially impacts long-term stability 
of lyophilized formulations. Solid-state hydrogen/deuterium (H/D) exchange with FTIR 
spectroscopy was employed to investigate this phenomenon and its potential impact on 
protein stability in the solid state. The studies demonstrated that the better stability in the 
rHSA:sucrose formulation correlated with lower extent of H/D exchange, which provides 
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Introduction   
Therapeutic proteins are a growing class of pharmaceuticals to treat a variety of 
diseases and the market is expected to increase with a compound annual growth rate of 
6.91% during the forecast period between 2012 and 2022 1. Proteins readily undergo 
chemical and/or physical degradation by numerous stress factors in solution. In 
particular, protein aggregates in sub-visible range have attracted great interest due to its 
potential implication in immunogenicity upon administration 2. To improve stability of 
this growing category of pharmaceutical products, freeze-drying is commonly used to 
prepare proteins in the solid state for distribution and storage. According to BCC 
research, until 2017, 35% of the marketed biotherapeutics are freeze-dried and freeze-
drying will soon be required for more than half of the injectable drugs 3. However, due to 
inherent challenges in both the freeze-drying process and formulation of proteins in the 
solid-state, efficient delivery of drug products with uniformly improved stability is not 
trivial. Application of the principles of Quality by Design (QbD) requires control of the 
entire freeze-drying process for assurance of product quality. Therefore, the 
understanding, control, and characterization of the process parameters as well as 
understanding the stabilization mechanism with added excipients in formulations is 
critical to a better control of the degree of degradation of the protein product.  
The effect of freezing parameters on protein stability 
The freezing step presents various stresses including cold denaturation, adsorption 
at ice/freeze-concentrate interface, removal of water, and increase of all solute 
concentrations through freeze-concentration 4,5. These stresses have been reported to 
cause irreversible protein damage including structural perturbation, aggregation, and/or 
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loss of biological activity 6. Further, the degree of supercooling varies from vial to vial 
both inter- and intra-batch, which results in variation in ice crystal size and potentially 
variation in protein damage at the ice/freeze-concentrate interface. It has been suggested 
that the formation of a large ice/freeze-concentrate interface during fast freezing causes 
denaturation of surface-active proteins such as lactate dehydrogenase (LDH) 4,7-13, 
catalase 9,14, human growth hormone (hGH) 15,16, bovine IgG 17, etc. The variation in the 
ice nucleation step necessitates the control of the freezing parameters for both process 
economic and product quality reasons. Several controlled ice nucleation techniques have 
been developed and the technology has been recently listed as an example of an emerging 
technology by the FDA emerging technology team 18. In addition to generally improving 
protein stability, controlled ice nucleation has the potential to improve batch uniformity 
in product quality 19,20. Challenges exist in scaling up the freeze-drying process from the 
laboratory to manufacturing, due to many factors including the difference in 
“spontaneous” ice nucleation temperature and heat transfer 21. If controlled ice nucleation 
can improve batch homogeneity, its use can improve scale-up from laboratory to 
manufacturing. Few controlled ice nucleation reports have focused on protein stability 
12,19; and very little information is available on the effect of controlled nucleation on the 
stability of proteins formulated with excipients. Investigations of the effect of controlled 
ice nucleation on average protein stability and batch uniformity in stability will contribute 
to the applicability and generalizability of controlling ice nucleation in the development 
of pharmaceutical proteins. 
Although the effect of ice nucleation temperature has gained increasing attention, 
how the freezing protocols after ice nucleation can influence protein stability is less well 
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understood. Such understanding is critical to designing a process for optimal protein 
stability. The increasing in the concentration of the solutes (i.e. protein, or any potential 
reactant) accompanied by ice formation presents a reactive environment for bimolecular 
reactions such as protein aggregation. This concept was supported by theoretical 
calculation of bimolecular reaction rate during freezing 6  and experimental observation 
of increased aggregation of plasmid/linear polyethylenimine polyplex particles arising 
from significant residence time in the freeze-concentrate 22.  When the proteins are 
exposed to the freeze-concentrate for a longer time due to a slower ramp rate or longer 
isothermal hold, aggregation may increase. On the other hand, ice crystals continue grow 
to larger size and may have the opportunity to remodel to lower a specific surface area, 
potentially reducing protein adsorption at the ice/freeze-concentrate interface. No 
experimental data is yet available to support this speculation. With the capability of 
controlling ice nucleation, it is now possible to study the factors post ice nucleation in 
practical freeze-drying conditions. A better understanding of whether the freezing 
protocols after ice nucleation can be advantageous or detrimental to protein stability will 
contribute to process design for optimal product quality.  
Shelf location-dependence of product resistance during primary drying due to a 
distribution in ice nucleation temperature 
How the ice crystals nucleate and grow affects the porous structure of the freeze-
dried solid. During the primary drying phase of lyophilization, water vapor passes 
through the porous partially dried layer, experiencing a resistance to mass flow, the so-
called product resistance (Rp). In a preliminary study, a location-dependent variation in 
ice nucleation temperature and cake morphology across the shelf was observed even 
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when ice nucleation was controlled. Existing methods to determine product resistance 
include Manometric Temperature Measurement (MTM) 23,24, utilization of mass flux 
from Tunable Diode Laser Absorption Spectroscopy (TDLAS) 25, and utilization of heat 
flux from the heat sensors adhered on the shelf surface; however, these approaches 
measure a batch-averaged Rp. Although the heterogeneity in sublimation rate and heat 
transfer in edge vials compared to center vials has been studied extensively 26, little is 
known about any differences in Rp based on vial location, i.e., between center and edge 
vials. Improved characterization of the Rp throughout primary drying would aid the 
optimization of process efficiency while maintaining product temperature below any 
critical value.   
 
Implication of protein internal dynamics on protein stability in the solid state during 
storage  
In addition to the freezing parameters, another critical factor in improving protein 
stability is to formulate proteins through the use of lyoprotectants such as sucrose or 
trehalose 27,28. The “water substitute hypothesis” through hydrogen bond formation with 
the protein molecule, and the “glass dynamics hypothesis” through reduced mobility in 
the rigid matrix are the two main stabilization mechanisms by the addition of 
disaccharides 29. In order to achieve optimal long-term stability, it is recommended that 
freeze-dried proteins should be stored below the glass transition temperature of the entire 
system (i.e., an assembly of protein molecules or protein molecules dispersed in a 
matrix).  However, there is an increasing body of work demonstrating that physical 
and/or chemical degradations still occur during storage at temperatures below the system 
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glass transition temperature (Tg) even with good glassy properties 30-32.  Moreover, there 
lacks a good correlation between protein stability and Tg at temperatures below Tg 29. 
Distinct DSC endotherm events, designated as “pre-Tg” endotherm, has been reported for 
insulin, hGH, and bovine serum albumin (BSA) in the solid state 33-35. These endotherms 
occur around 50°C, which is well below the system Tg for pure solid proteins 34,35. 
Internal dynamic transition on the protein molecule was attributed as the origin of the 
pre-Tg endothermic events and was proposed to have stability implications 30,36. In 
principle, effective coupling between the protein internal dynamics and the dynamics of 
the inert matrix should provide the best stability. However, systematic experimental data 
is lacking. Understanding the role of excipients on internal dynamics of the protein 
molecule will contribute to formulation design for optimal storage stability.   
Protein dynamical temperature (Td) 
The hypothesis of “protein internal dynamics” in dry proteins was adapted from 
the concept of a glass transition temperature within individual protein molecule, known 
as the Td. Td was introduced to describe local fluctuations of protein residues and was 
well studied in systems with high water/polyol content and in sugar/water glassy 
matrices, but very little work has been done in dry proteins 37-39.  
Inelastic neutron scattering has been used to investigate the vibrational and 
diffusive motions in myoglobin with 36% (w/w) water 37. The binding of oxygen to the 
myoglobin molecule requires higher degree of protein flexibility and density fluctuation. 
The detected onset of protein motion of myoglobin according to the change in scattering 
function was above -90°C, which was consistent with the reported onset of oxygen 
diffusion around -73°C. The temperature at which protein internal motion is activated to 
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allow effective oxygen binding was referred to as protein dynamical temperature. Protein 
molecules demonstrate many degrees of molecular motion from smaller-scale local 
motion such as atomic fluctuations (10-15-10-1 s), rigid-body motions including helix, 
domains, and subunit motions (10-9-1s) to larger-scale motions of protein segments such 
as helix-coil transition, folding and unfolding transitions (10-7-104 s) 40. Considering 
protein residues as small molecules, it would be argued that the local motions in protein 
residues might share glass-like properties. This is evidenced by another study on infrared 
C=O stretching bands of CO-myoglobin after flash-photolysis, which suggested that 
proteins and small molecule glasses share common characteristics including meta-
stability below glass transition temperature and relaxation behavior following non-
exponential Kohlrausch-Williams-Watts (KWW) relaxation 41,42. 
The implication of protein internal dynamics on protein stability in solid state 
Given that protein molecules demonstrate glass-like properties including the 
KWW non-exponential relaxation behavior due to combined relaxation of a number of 
conformational sub-states, it could be argued that the local non-diffusive movement of 
the amino acids within proteins may lead to segmental fluctuations, therefore resulting in 
cooperative larger-scale motion 30,43-46.  Evidence of loss in protein function at Td has also 
been reported 47-49. The potential stability implication of the protein dynamical 
temperature in solid protein formulations of pharmaceutical significance has been 
emphasized 43. At temperatures exceeding the protein dynamical temperature, there is an 
increase in local internal motions, which eventually result in larger cooperative motions, 
and therefore may have significant stability implications.  
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It is worth noting that protein internal dynamics could be controlled by 
modulating the dynamical temperature, Td, through the degree of hydration and 
lyoprotectant content/type 38,39,42,43,50,51. Hill and co-workers suggested that it is the 
hydrogen bonding interactions between water and the amino acid residues that facilitates 
the propagation of fast β-like motions into larger scale α-like motions, which are 
responsible for protein internal dynamics. Studies on the kinetics of ligand binding to 
carbon monoxymyoglobin in a dry trehalose system demonstrated that the glassy 
trehalose suppressed the inter-conversion of protein conformation sub-states, suggesting 
that protein internal motion is limited or locked in the relatively more rigid matrix 52. 
Therefore, effective coupling between protein internal dynamics and the dynamics of the 
matrices may play an important role in the stability of protein pharmaceuticals.  
A full understanding of the effect of the freezing parameters and dynamic 
coupling of the protein internal dynamics with the dynamics in the formulation matrix 
will contribute to process and formulation design for optimal protein stability in the solid 
state. 
Objectives and aims 
The overall objective of this work is to investigate freeze-dried protein quality 
attributes affected by stress factors arising from the freezing step of the lyophilization 
process (ice nucleation temperature, residence time in the freeze-concentrate, etc.) and by 
dynamic coupling of protein molecule and the formulation matrix. Fundamental 
understanding of the stresses on the protein during freezing and the implication of protein 
internal dynamics will provide information critical to the efficient formulation and 
process design.  
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The specific aims are: 
1. To study the effect of two freezing parameters (ice nucleation temperature and 
residence time in the freeze-concentrate) on stability of protein formulations during the 
freeze-drying process and long-term storage. 
2. To address whether product resistance during primary drying is shelf location-
dependent due to an observed distribution of ice nucleation temperature within a batch.   
3. To investigate the origin of pre-Tg endothermic events in pure solid proteins and 
further to explore the implication of the attributed protein internal dynamics on protein 
stability in the solid state.  
 
Organization of the Dissertation 
Large natural variations exist in ice nucleation temperature across the batch. Chapter 2 
presents a focused study on the effect of controlling ice nucleation temperature on 
stability of a model protein known to be sensitive to the ice surface, lactate 
dehydrogenase (LDH), formulated without any stabilizer. Both average stability of LDH 
within a batch and homogeneity in stability were evaluated when the samples were frozen 
at various controlled ice nucleation temperatures as compared to the freezing condition 
without ice nucleation control. This study provides direct evidence of improved protein 
stability during freeze-thawing when ice nucleation was controlled at a higher 
temperature. Interestingly, a higher ice nucleation temperature did not show a vastly 
superior stability in LDH after the entire freeze-drying process. This work was the first 
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report that demonstrated improved batch uniformity in protein stability using the 
controlled ice nucleation technology, ControLyo™. 
 
Very little information is available on the effect of controlled ice nucleation on the 
stability of proteins formulated with excipients. Moreover, it is less well understood what 
the critical factors are attributed to protein stability post ice nucleation. Chapter 3 
extends the study of the freezing parameters on protein aggregation during the freeze-
drying process and storage. Two model proteins were used in the study including 
intravenous immunoglobulin (IVIG) and recombinant human serum albumin (rHSA) and 
were formulated with or without the presence of a stabilizer, sucrose. In addition to the 
ice nucleation temperature, the shelf ramp rate and isothermal hold were varied after ice 
nucleation. The two opposing effects after ice nucleation (ice surface area and residence 
time in the freeze-concentration) were proposed to affect protein aggregation. A good 
correlation was found between residence time and protein aggregation. This study 
provided experimental evidence in supporting the residence time in the freeze-
concentrate as the critical factor in protein aggregation. The results are directly relevant to 
process design in bulk freezing and thawing when the freezing time is much longer.  In addition 
to stability, characteristics of the final solid including morphology and porous structure were 
characterized at various freezing conditions using the polymer encapsulation method, mercury 
intrusion porosimetry method and specific surface area measurements. The findings suggest that 
it is not only the ice nucleation temperature, but also the thermal history post ice nucleation that 
define the surface area of ice and the porous structure of the freeze-dried cake. 
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A distribution in ice nucleation temperature within a batch was observed even when ice 
nucleation was controlled at a fixed time and shelf temperature. In existing literature, the 
resistance to mass flow during primary drying, product resistance (Rp) was determined as 
a batch average.  Chapter 4 attempts to address whether there is a shelf location-
dependent Rp due to the distribution in ice nucleation temperature. The calculation of 
real-time Rp in individual vials was described and the challenges using this “direct vial” 
method were addressed. The correlation between ice nucleation temperature, specific 
surface area, and Rp in center vials was established to estimate Rp in samples placed at 
other locations of the shelf (i.e. edge vials). This study filled the gap in the area of 
understanding whether Rp is dependent on the location of the vial and provides insights in 
developing methods to accurately measure real-time Rp in individual vials.  
 
Endothermic events were previously reported in DSC thermograms of pure insulin and 
hGH in the solid state; the events occurred at temperatures well below the glass transition 
temperature of the system, referred to as pre-Tg. Chapter 5 discusses and studies the 
origin of the pre-Tg endothermic events. Enhanced internal motion on the protein 
molecule in that temperature range was proposed to be the underlying cause of the pre-Tg 
events. This phenomenon, protein internal dynamics, was studied by solid-state 
hydrogen/deuterium (H/D) exchange in conjunction with FTIR spectroscopy. This work 
presents a new concept based on existing knowledge about the dynamics on the protein 
molecule and supported previously reported instability at temperatures lower than the 
system glass transition temperature.  
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Chapter 6 is a continued exploration on whether the protein internal dynamics studied in 
Chapter 5 has any stability consequence in protein formulations in the solid state. Soluble 
aggregation during storage was evaluated in rHSA freeze-dried with sucrose or trehalose. 
The sucrose formulation showed better stability than trehalose during storage. To further 
explore the underlying mechanism of the better stability offered by sucrose, both the 
protein secondary structure by FTIR spectroscopy and dynamic property by solid-state 
H/D exchange were evaluated. Both formulations showed similar secondary structure 
features. The dynamical temperature, Td appears to not correlate with stability in rHSA 
systems. However, it found that the lower extent of H/D exchange in the sucrose 
formulation correlated with its better stability compared to the trehalose formulation.  
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Abstract 
 Several controlled ice nucleation techniques have been developed to increase the 
efficiency of the freeze-drying process as well as to improve the quality of 
pharmaceutical products. Due to the reduction in ice surface area, these techniques have 
the potential to reduce the degradation of proteins labile during freezing. The objective of 
this study was to evaluate the effect of ice nucleation temperature on the in-process 
stability of lactate dehydrogenase (LDH). LDH in potassium phosphate buffer was 
nucleated at -4°C, -8°C, and -12°C using ControLyo™ or allowed to nucleate 
spontaneously. Both the enzymatic activity and tetramer recovery after freeze-thawing 
linearly correlated with product ice nucleation temperature (n=24). Controlled nucleation 
also significantly improved batch homogeneity as reflected by reduced inter-vial 
variation in activity and tetramer recovery. With the correlation established in the 
laboratory, the degradation of protein in manufacturing arising from ice nucleation 
temperature differences can be quantitatively predicted. The results show that controlled 
nucleation reduced degradation of LDH during the freezing process, but this does not 
necessarily translate to vastly superior stability during the entire freeze-drying process. 
The capability of improving batch homogeneity provides potential advantages in scaling-
up from lab to manufacturing scale.  
 
Keywords: 
Freeze drying/Lyophilization; Ice Nucleation; Protein formulation; Solid state stability; 
Quality by design (QbD) 
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Introduction 
Many therapeutic proteins are freeze-dried to improve their storage stability, 
since stability in the aqueous solution state is often insufficient for distribution and 
storage of this growing category of pharmaceutical products. However, freezing can 
cause irreversible protein damage including aggregation, and/or loss of biological activity 
1. There are four major stress factors that reduce protein stability during freezing, 
including cold denaturation, structural perturbation at the ice/water interface, removal of 
water, and increase of all solute concentrations through freeze-concentration 2,3. Protein 
stability can be quite sensitive to the details of the freezing method. Therefore, 
appropriate control of the freezing process has the potential of providing better control of 
the degree of degradation of the protein product.  
Freezing is normally uncontrolled in the conventional freeze-drying process. The 
cooling rate of the shelf is controlled; however, shelf cooling rate only controls freezing 
post ice nucleation. Since ice nucleation is a stochastic process, the degree of super-
cooling varies from vial to vial both inter- and intra-batch, which results in variation in 
ice crystal size and potentially in protein damage at the ice/water interface. Improvement 
in stability of protein formulations has been reported at freezing conditions that reduce 
ice crystal surface area 4-7 such as slow cooling or annealing, but none of these reports 
used controlled ice nucleation. It has been suggested that the formation of a large 
ice/freeze-concentrate interface during fast freezing causes denaturation of surface-active 
proteins such as lactate dehydrogenase (LDH) 2,4,8-13, catalase 4,14, human growth 
hormone (hGH) 6,7, bovine IgG 15, etc. Sarciaux and coworkers reported more insoluble 
aggregates when bovine IgG was rapidly cooled (by quenching in liquid nitrogen) versus 
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slower cooling at 2°C/min. Moreover, the degree of insoluble aggregate formation was 
protein concentration dependent, with higher degradation observed at lower protein 
concentration, suggesting an interfacial phenomenon 15. Cochran and Nail reported an 
inverse correlation of LDH (50 µg/mL, pH 7.4) activity recovery after freeze-drying with 
the degree of super-cooling, suggesting a larger degree of protein degradation at the 
higher ice/freeze-concentrate interfacial area which results from a greater degree of 
supercooling 9. However, there was significant “scatter” in the data, due to large variation 
in the enzymatic activity assay. Another possible reason for the scatter is lack of ice 
nucleation control.  
Perhaps control of the ice nucleation temperature will provide a clearer picture to 
evaluate the correlation between ice nucleation temperature and LDH activity recovery. 
In one study, temperature-controlled sample wells were used 8, rather than glass vials, in 
order to achieve rapid cooling (45-60s; i.e., from +5°C to -5°C, -10°C, -15°C, -20°C, or -
25°C). Ice formation was initiated by dipping a cold ice covered platinum wire into the 
solution at the desired final temperature to control the onset of ice formation in this study 
of the degradation of LDH (5 µg/mL, pH 7.4). The study suggested ice formation as the 
critical factor in destabilizing LDH. The ice crystals leave fingerprints as pores formed in 
the freeze-dried solid. The ice surface area, which is the surface area of the freeze-dried 
solute, can be easily measured by the specific surface area (SSA) of the freeze-dried 
product 8. It has been reported that SSA of freeze-dried materials was lower when ice 
nucleated at a higher temperature 16. However, in the study by Bhatnagar et al., there was 
no significant difference in activity recovery of samples when ice was nucleated at -2 
versus -9.5°C, which is contrary to what would be expected. A study of a catalase 
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formulation (1.7 µg/mL) revealed 60% loss of activity at a lower ice nucleation 
temperature (-10°C) controlled by seeding, compared to 25% activity loss at higher ice 
nucleation temperature (-2°C) 14. More recently, lyophilized hGH was shown to be less 
stable when a larger fraction of protein was found at the surface of the solid phase, where 
this fraction varied with the details of the freezing process largely due to variation in 
specific surface area 6. Collectively, these reports suggest that protein stability can be 
improved by manipulating the freezing parameters, such as ice nucleation temperature 
and perhaps cooling rate, although other factors specific to the protein may also be 
important.  
Several techniques have been developed to control the ice nucleation at fixed 
time and temperature and thereby minimize primary drying time as well as improve batch 
homogeneity 17-21. Ice nucleation controlling techniques including ControLyo™ 22 can 
potentially reduce the degradation of proteins labile at ice/aqueous interface. However, 
early on, there were concerns that ControLyo™ would destabilize protein during sudden 
depressurization that could potentially form small bubbles and/or introduce cavitation, 
both effects being potentially damaging to protein stability. Preliminary work (Sever and 
Pikal, unpublished data) showed the stability of hGH in sucrose formulations was in fact 
improved using ControLyo™ at a higher ice nucleation temperature than uncontrolled ice 
nucleation.  
In addition to generally improving protein stability, controlled ice nucleation has 
the potential to improve batch uniformity in product quality. It is well known that the ice 
nucleation temperature is sensitive to the presence of heterogeneous nucleation sites. 
Fewer and/or different airborne particulates, different vial processing, and therefore fewer 
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or less effective heterogeneous nucleation sites in manufacturing probably accounts for 
the lower average ice nucleation temperature observed in production operations relative 
to laboratory environments 16,23. The difference in average “spontaneous” ice nucleation 
temperatures in lab and production environment presents a serious challenge for scaling 
up in freeze-drying. If, as is expected, controlled ice nucleation can improve batch 
homogeneity, its use can improve scale-up from laboratory to manufacturing. Application 
of the principles of Quality by Design (QbD) requires control of the entire freeze-drying 
process, including freezing, or at a minimum, demands an understanding of the impact of 
uncontrolled nucleation on product quality for representative products 24.  For both 
product quality and process economic reasons, techniques to control ice nucleation and 
growth are needed to ensure consistent product quality and lower costs. Such techniques 
are now available for both laboratory and manufacturing, and have been critically 
reviewed 25. 
In the present study, the objective was to investigate the effect of a controlled ice 
nucleation technique on the average stability and batch uniformity in stability of a protein 
that shows strong evidence of degradation during freezing due to the presence of ice. 
Pure LDH at a very low concentration was chosen as the model protein to study the 
impact of ice nucleation temperature. This formulation is not a representative protein 
product. However, previous studies clearly implicated interaction with the ice as the 
primary “stress” during freezing, and LDH satisfies this requirement better than any other 
system with which we are familiar. ControLyo™ (controlled ice nucleation by 
depressurization) was used to control the ice nucleation temperature.  
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Materials and Methods 
Materials  
       L-Lactic dehydrogenase from rabbit muscle (EC 1.1.1.27) was purchased from 
Sigma-Aldrich (a suspension in 3.2 M ammonium sulfate, St. Louis, MO).  All other 
reagents were reagent grade or higher quality (Sigma-Aldrich, St. Louise, MO or Fisher 
Scientific, Waltham, MA). Rubber stoppers, (2-prong with outer diameter 20 mm) and 10 





  LDH was dialyzed against 100 mM potassium phosphate buffer (pH 7.3) with a 
10K MWCO membrane for 3 hours twice and the third buffer exchange for overnight at 
4°C. The concentration of LDH was determined from UV absorbance (extinction 
coefficient 1.44 mL/mg-cm at 280 nm).  The LDH solution was diluted with purified 
water (0.22 µm-filtered) and potassium phosphate buffer in order to formulate 10 µg/mL 
of LDH in 5 mM potassium phosphate buffer (pH 7.3).  Two milliliters of the sample 
solution were filled into each 10 mL vial (for a fill depth of 0.6 cm) and were partially 
stoppered with rubber stoppers. 
 
Freeze-thawing and freeze-drying 
  The ControLyo™ system (SP Scientific, Gardiner, NY) was used for both freeze-
thawing and freeze-drying studies. LDH solution in 10 mL vials was placed at specific 
locations on the shelf, with three vials in the center, and one each in the front, back, and 
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edge position of the shelf. Non-sample vials filled with water (2 mL) surrounded the 
sample vials to partially fill the shelf. The temperatures of the 6 LDH vials were 
monitored during the freezing process with thermocouples glued with thermal grease to 
outside of the vials near the vial bottom. For uncontrolled freezing, the LDH solutions 
were equilibrated in the freeze-dryer at 5°C for 30 minutes, then the shelf was cooled to -
40°C at 1°C/min and held for 1 hour. The nucleation of ice in the LDH solutions was 
controlled at the desired shelf temperatures (-4, -8, -12°C) and frozen according to the 
recipe shown in Table 1. Preliminary tests showed that the activity of LDH solution was 
time-dependent after thawing. Therefore, for the freeze-thawing study, products were 
removed from the freeze-dryer after freezing and allowed to thaw at room temperature, 
which took approximately 15 minutes. Then the enzymatic activity and tetramer recovery 
were measured immediately after thawing.  
  For the freeze-drying study, the LDH solutions were frozen under uncontrolled or 
controlled ice nucleation at -4°C following the same protocol for freezing as described as 
above. For primary drying, the chamber pressure was set at 100 mTorr and the shelf 
temperature was heated at 0.5°C/min to -28°C and held constant. When the Pirani gauge 
reading converged with the capacitance manometer reading, the shelf temperature was 
raised at 0.2°C/min to 25°C and held for 2 hours with the chamber pressure maintained at 
100 mTorr. The freeze-dried product was reconstituted with 2.0 mL of water and the 
activity and tetramer recovery were measured immediately after reconstitution.  
  
Enzymatic activity assay 
The activity of LDH was determined by monitoring the decreasing of absorbance 
at 340 nm with a UV/VIS spectrophotometer (Cary Bio100, Varian Inc., Palo Alto, CA) 
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resulting from hydrolysis of nicotinamide adenine dinucleotide (NADH). Fifty 
microliters of each thawed or reconstituted LDH sample (10 µg/mL) were added to a 
mixture of 30 mM sodium pyruvate and 6.6 mM NADH in 100 mM potassium phosphate 
buffer at room temperature. Cary WinUV Software in kinetics mode was used for data 
acquisition and analysis. Results are reported as remaining percent (%) of activity relative 
to initial values prior to freezing.	  
 
Tetramer recovery by size exclusion chromatography (SEC) 
  The LDH solution was filtered (0.45 µm polyvinylidene difluoride filter, Thermo 
Fischer Scientific, Waltham, MA) and 50 microliters was injected onto a SEC column 
(TSKgel™ G3000SWXL, 7.8 mm x 30 cm, 5 µm, Tosoh Bioscience, San Francisco, CA) 
maintained at 25°C. The mobile phase was 100 mM phosphate buffer with 0.2 M NaCl 
(pH 7.0) delivered at 1.0 mL/min. The HPLC (model 1100, Agilent, Santa Clara, CA) 
was connected to a diode array detector, with which absorbance was measured at 220 nm 
(model G1315A, Agilent). Chemstation software (Agilent) was used for data acquisition 
and analysis. The intensity of the lowest tetramer peak used in the data set was ten times 
the background noise intensity. Results are reported as a remaining percent (%) of 
tetramer contents to initial values prior to freezing. 
 
Statistical analysis 
  One-way analysis of variance (ANOVA) was applied to evaluate whether there 
was statistical significance in stability differences due to the drying step between the two 
freezing conditions (uncontrolled ice nucleation versus controlled ice nucleation at shelf 
temperature of -4°C). All variation was expressed as standard deviation.  
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Results and Discussion 
Freeze-thawing study 
  Using conventional freezing, ice nucleated randomly over a wide temperature 
range, as seen from the sudden rise in product temperature (Figure 1A), when the 
exothermic crystallization first occurs. Moreover, often a second “temperature jump” 
prior/post ice nucleation was observed, representing the heat transferred from 
neighboring vials undergoing ice nucleation at lower temperatures. In contrast, uniform 
ice nucleation was observed upon depressurization to initiate nucleation at shelf 
temperatures of -4 and -8°C (Figure 1B, 1C). However, it was difficult to achieve 
uniform ice nucleation when attempting control of ice nucleation at lower temperatures 
such as -12°C; one out of the six vials nucleated spontaneously prior to depressurization 
(Figure 1D). Controlled ice nucleation was initiated at a given shelf temperature, but the 
ice nucleation temperature of the LDH solution in the vials was higher (Table 2). Ice 
nucleation was controlled at average product temperatures of -3.1°C, -6.9°C, and -10.2°C 
when the solution was equilibrated at shelf temperatures of -4, -8, -12°C, respectively 
(Table 2). In the case of uncontrolled nucleation, the average ice nucleation temperature 
was lower (-14.4°C) than for the controlled nucleation conditions (Figure 1, Table 2). 
Significantly higher average activity of LDH (89.8 ± 0.6%) was retained for solutions in 
which ice nucleation was initiated across the batch at a shelf temperature of -4°C (product 
temperature -3.1 ± 0.4°C) compared to uncontrolled nucleation occurring spontaneously 
in each vial (75.3 ± 2.3%) (Figure 2). The activity improved linearly with an increase in 
ice nucleation temperature of the LDH solutions (n=24, R2=0.83) (Figure 3).  
  The loss of LDH activity during freeze-thawing was reported to correlate well 
with the dissociation process from the native tetramer (142 kDa) to the dimeric subunits, 
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which have lower activity 11,26. Further, Bhatnagar et al. reported that the reassociation 
from dimer to tetramer occurred upon freeze-concentration at -5°C, and slowly 
dissociated back to dimer during thawing 27. In the present study, the time from thawing 
to measurement was maintained constant, with the tetramer recovery of LDH solution in 
vials analyzed immediately after freeze-thawing. Tetramer recovery was 75.8 ± 2.4% for 
uncontrolled ice nucleation (average ice nucleation temperature -14.4°C). The recovery 
progressively improved as ice nucleation was controlled at higher temperatures; 76.6 ± 
1.0%, 79.8 ± 0.8%, 81.5 ± 1.0%, for control at shelf temperatures of -12, -8, -4°C, 
respectively. A correlation (R2=0.70, n=24) was observed between tetramer recovery 
measured by SEC and the LDH solution ice nucleation temperature (Figure 4). This 
observation further supports the strong correlation between the enzymatic activity 
recovered and the ice nucleation temperature of the LDH solution (Figure 3).  
  The observed higher recovery of activity of LDH agrees with generally accepted 
finding of reduced surface area of ice crystals expected at higher ice nucleation 
temperature. While the current study is focused on LDH, other proteins are also 
susceptible to increased degradation in formulations that have high SSA of ice 6,14,15. 
However, it should be noted that improvement in the in-process stability is expected to be 
greatest for low to moderate protein concentrations where a substantial fraction of the 
protein is likely located at the surface. Formulations with high concentrations of protein 
or substantial lyoprotectant levels may not show significant loss of activity or increase in 
aggregates after freeze-drying. 
 Batch homogeneity is expected to improve with ice nucleation controlled at a 
higher temperature. An improvement in batch drying rate 12 and low standard deviation in 
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SSA 19 have been reported when ice nucleation is controlled, thereby reducing the 
variation in nucleation temperatures across the batch. Passot et al. demonstrated that the 
greatest batch homogeneity was obtained by using a nucleation agent in the formulation, 
followed by precooling the shelf and employing an ultrasound method 12. In the present 
study, a commercially available ice nucleation technology was employed. The variation 
in the product temperature at which ice nucleated is expressed as the standard deviation 
of the 6 vials at different locations (Table 2). Ice nucleation control at a particular shelf 
temperature improved the uniformity of ice nucleation temperatures of the 6 vials, despite 
the vial locations that are generally considered to have a large position dependence in 
heat transfer 28 – three vials in the center, and one each in the front, back, and edge 
position of the shelf. The LDH solution in all vials nucleated simultaneously at which ice 
nucleation was controlled (Figure 1B, C) except that one sample nucleated prior to 
depressurization in the case of -12°C (Figure 1D); thus, heterogeneity in ice nucleation 
temperature was significantly reduced compared to the uncontrolled ice nucleation batch 
(Table 2). To further investigate the potential improvement in batch homogeneity in 
protein stability, the variation in activity and tetramer recovery of LDH was evaluated in 
the 6 individual vials frozen at extremes in shelf position under various freezing 
conditions. The standard deviation of LDH activity recovery after freeze-thawing was 
lowest under controlled ice nucleation at -4°C compared to uncontrolled nucleation (± 0.6 
vs. ± 2.3). Similarly, the standard deviation of tetramer recovery was reduced by about ½ 
under controlled ice nucleation (± 1.0 vs. ± 2.4) (Figure 4). In addition, the variability in 
stability data increases as ice nucleation temperature decreases, even when ice nucleation 
is controlled (at -4, -8, -12°C). Spontaneous nucleation in some of the vials prior to 
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reaching the controlled ice nucleation temperature could in principle be the cause of the 
higher variation at -8 and -12°C. In this case, there was only one vial in the -12°C 
experiment that nucleated spontaneously prior to depressurization, and none in the case 
of controlled ice nucleation at -8°C. The improvement in batch homogeneity resulting 
from controlled ice nucleation at a higher temperature facilitates scale-up and the 
development of a more robust freeze-drying process, and therefore plays an important 
role in QbD. 
Freeze-drying study 
  In addition to stresses that proteins experience during freezing, the drying step 
often causes greater protein degradation due to dehydration 1. In the present study, we 
note further degradation of LDH during the drying stages. A previous study demonstrated 
a correlation between ice nucleation temperature and activity recovery of reconstituted 
LDH solution after freeze-drying, but with significant scatter in the data 9. Here, we 
confirm these earlier findings using controlled ice nucleation and also characterize 
tetramer recovery of the freeze-dried LDH products for both uncontrolled ice nucleation 
and nucleation controlled at -4°C. In the case of conventional freezing without control of 
ice nucleation, there was a wide range in ice nucleation temperature as well as multiple 
“jumps in temperature” suggesting ice nucleation in a neighboring vial occurred at a later 
time and lower temperature (Figure 5A). The ice nucleation profile is different from 
uncontrolled ice nucleation experiments conducted during the freeze-thaw study, 
suggesting the thermal history of products during freezing is not reproducible inter-batch. 
However, when using controlled ice nucleation, relatively more homogenous ice 
nucleation temperature was obtained (Figure 5B and Table 3). The temperature history of 
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all samples is remarkably consistent. It should be noted that the edge vial placed in the 
front row facing the door nucleated at the highest temperature indicated by the arrow 
(Figure 5B), and remained at a higher temperature for a much longer time at the 
equilibrium freezing point than other vials. The resulting activity recovery is 56.4% for 
uncontrolled ice nucleation with average product temperature of -14.2°C, and 62.4% for 
controlled ice nucleation with average product temperature of -2.2°C (Figure 6A). The 
difference was significant (α=0.01) based on one-way ANOVA analysis. Additionally, the 
improvement in tetramer recovery was significant for controlled ice nucleation (49.6%) 
compared to uncontrolled ice nucleation (44.0%) (Figure 6B).  
  To separate the % activity loss on drying, we assume that the % activity after 
freeze-thawing (Figure 2) is the % activity after the freezing step of freeze-drying. For 
example, uncontrolled ice nucleation resulted in 75.3% activity remaining after freeze-
thawing. After freeze drying, the % activity based on the initial pre-lyophilized solution 
was 54.4%. Thus, 18.9 ± 0.6% activity (i.e., 75.3% minus 56.4%) was lost on drying 
without control of ice nucleation versus 27.4 ± 1.4% (i.e., 89.8% minus 62.4%) for 
controlled nucleation at -4°C. In fact, the loss in activity during drying was larger for 
controlled ice nucleation (27.4%) than for uncontrolled ice nucleation (18.9%). The loss 
in tetramer during drying is the same for the two conditions (31.8 ± 0.8% vs. 31.9 ± 
0.2%). Thus, controlled ice nucleation offered less protection during the entire freeze-
drying process than during freezing itself. Greater protein damage during the drying step 
partially erased the activity differences arising from different ice nucleation temperatures 
during freezing. The question remains: why should a sample produced with a higher ice 
nucleation temperature (-4°C) show more degradation during drying than the same 
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composition that begins freezing at a lower temperature and presumably has a higher 
specific surface area of ice (and solute)? We do not have a satisfactory explanation for 
this observation. Presumably, this additional degradation occurs during secondary drying 
since there is little to no evidence that significant degradation occurs during primary 
drying, even with collapse, and degradation does occur during secondary drying 29. 
 
Implications for extrapolating lab data to protein stability at manufacturing scale 
  In the manufacturing environment, much smaller ice crystals and higher ice 
surface area are expected, since ice may nucleate at temperatures lower than -20°C in 
manufacturing operations. It has been noted that the average ice nucleation temperature 
in manufacturing can be about 10°C lower than in the laboratory for a given formulation 
23. Further, in the laboratory and presumably also in manufacturing, the range in ice 
nucleation temperatures for a given product can span 10°C or more (unpublished data in 
collaboration with Praxair). Therefore, for proteins susceptible to damage at the 
ice/aqueous interface, both the average and the variation in lyophilized product quality 
are expected to be significantly different when processed in the lab versus in a 
manufacturing environment.  
  The correlation established between ice nucleation temperature and stability, 
using LDH as a model (Figure 3) can be used to quantitatively estimate protein 
degradation. Based on laboratory data from Praxair, the ice nucleation temperatures 
follow a Gaussian distribution with average ice nucleation temperature at -13°C and a 
span of 10°C (Figure 7). It was suggested that the average ice nucleation temperature is 
10°C lower than in the laboratory environment 16,23. Assuming the same distribution of 
ice nucleation temperature (without controlled nucleation) applies in manufacturing, the 
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average LDH activity after freezing is expected to be 11.4% lower than in lab scale. The 
activity recovery can be as low as 60% for 5% of the product with the lowest expected 
ice nucleation temperature of -28°C. The correlation coefficient between stability after 
freeze-drying and the ice nucleation temperature was low (R2=0.60) after freeze-drying 
since less difference is seen between the two extreme conditions, controlled ice 
nucleation at -4°C and uncontrolled nucleation. There is expected to be a ~4% decrease 
in activity or tetramer recovery for a 10°C decrease in ice nucleation temperature. 
Significant differences in average product quality between laboratory and manufacturing 
are likely for any product susceptible to damage at the ice/aqueous interface. Overall, 
lower variability within a production batch using controlled ice nucleation should be 
expected for all products.	  
 
Conclusions 
  LDH, which is well-known as a protein labile at the ice/freeze-concentrate 
interface, was frozen using controlled ice nucleation at several temperatures and by 
spontaneous uncontrolled nucleation. Both higher enzymatic activity and tetramer 
recovery correlated well with higher ice nucleation temperatures after freeze-thawing. 
This result is consistent with previous findings that ice nucleation at relatively high 
temperatures produces larger ice crystals and therefore low ice/aqueous interfacial area. 
However, since greater degradation occurs during drying for controlled ice nucleation 
(i.e., higher ice nucleation temperature and presumably less SSA), the total in-process 
stability was only slightly (~6%) better for controlled ice nucleation. The results indicate 
that the controlled nucleation technique has the potential to minimize degradation during 
the freezing process for pharmaceutical protein products that are labile at ice/freeze-
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concentrate interface. However, controlled ice nucleation does not necessarily translate to 
vastly superior stability throughout the entire freeze-drying process, at least in the case of 
low concentrations of pure LDH. In general, controlling ice nucleation at a higher 
temperature is most beneficial in improving the average in-process stability for low to 
moderate protein concentrations without stabilizers. In addition to the impact on protein 
stability, the improvement in batch uniformity using controlled ice nucleation contributes 
to better control and development of a more robust freeze-drying process that is easier to 
scale up to manufacturing, and this result is expected to be general. ICH guidelines 
require controlling the critical process parameters (CPP) that affects critical product 
quality attributes (CQA), such as stability. The numerous studies 9,14 in the literature, as 
reviewed in the introduction, as well as the current study report that ice nucleation 
temperature can impact protein stability, indicating that it should be considered a 
potential CPP unless shown otherwise. However, as noted above, the net effect on 
stability during the entire freeze-drying process can be complex. Unfortunately, the ice 
nucleation temperature is currently uncontrolled in nearly all manufacturing plants. Given 
the availability of ice nucleation control technology for manufacturing, this situation will 
likely change in the future.  
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Table 1. Freezing recipe for controlled ice nucleation 
Step 1 2a 3b 4c 
Shelf temperature set point (°C) 5.0 -4.0/-8.0/-12.0 -4.0/-8.0/-12.0 -40.0 
Ramp rate (°C/min) 5 1 0 1 
Hold time (min) 30 60 15 60 
 
Pressurization after step 2 (to 28.5 psig with argon gas), depressurization after step 3 (to 
2.0 psig) 
aThe shelf temperature was cooled down to the target temperature, -4, -8 or -12°C, at the 
rate of 1°C/min and was held for 60 minutes. After that, the chamber was pressurized to 
28.5 psig with argon gas. 
bThe shelf temperature was held at each target in the pressurized chamber for 15 
minutes. After that, the chamber was depressurized to 2.0 psig rapidly. There was a 
small increase in product temperature (0~0.2°C for control of ice nucleation at -4°C and 
-8°C, and 0~0.6°C for control at -12°C) during the 15 minutes equilibration after 
pressurization.  
cThe shelf temperature was cooled down to -40°C at the rate of 1°C/min and was held 











Table 2. Comparison of product ice nucleation temperatures in each freezing condition 
Ice nucleation conditions Uncontrolled Controlled at shelf temperature 




Averagea -14.4 -3.1 -6.9 -10.2 
Std Deva 1.7 0.4 0.5 1.1 
Maximum -12.9 -2.6 -6.3 -8.9 
Minimum -17.4 -3.6 -7.4 -11.5 
Max - Min 4.5 1.0 1.1 2.6 
aAverage and standard deviation (Std Dev) were calculated with the values of 6 
individual vials located at the center, edge, front and back of the shelf. The 




















Table 3. Comparison of ice nucleation temperatures in each freezing process of the 
freeze-drying study 




Averagea -14.2 -2.2 
Std Deva 2.2 0.7 
Maximum -12.1 -0.9 
Minimum -17.9 -2.8 
Max - Min 5.8 1.9 
aAverage and standard deviation (Std Dev) were calculated with the values of 6 
individual vials located at the center, edge, front and back of the shelf. The 
















Figure 1. LDH temperature profiles during the freezing process of the freeze-thaw study 
A) Uncontrolled nucleation                  B) Controlled nucleation at shelf temperature -4°C 











Figure 2. LDH activity recovery after freeze-thawing. Values are expressed as average ± 
standard deviation of 6 individual vials located at the center, edge, front and back of the 












Figure 3. Correlation between the ice nucleation temperature of the LDH solutions and 
LDH activity recovery after thawing. Black diamonds represent the values of individual 
vials. White squares and error bars represent the average and standard deviations of 6 











Figure 4. Correlation between the ice nucleation temperature of the LDH solutions and 
and LDH tetramer recovery. Black diamonds represent the values of individual vials. 
White squares and error bars represent the average and standard deviations of 6 vials in 











Figure 5. LDH temperature profiles during freezing process of the freeze-drying study.  
















Figure 6. LDH recovery after freeze-drying.  
A) Activity recovery (%) by enzymatic activity assay, B) Tetramer recovery (%) by SEC. 













Figure 7. Distribution of ice nucleation temperature in laboratory at Praxair (private 
communication with Robert Sever). A total of 42 readings were collected. % Value in the 
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Chapter 3 
Stability of Freeze-Dried Protein Formulations: Resolving the Contributions of Ice 


















	   54	  
Abstract 
 ControLyo™ is one of the ice nucleation-controlling techniques to improve 
process efficiency and product quality. Controlling ice nucleation at a fixed higher 
temperature results in larger ice crystals, which can reduce the ice/freeze-concentrate 
interface where proteins can adsorb and degrade. Moreover, protein stability seems to 
suffer from opposing effects during ice crystal growth post ice nucleation, and limited 
work has been done to address any effects on protein stability due to a slow ramp or long 
isothermal hold after ice nucleation. The objective was to evaluate the impact of the ice 
nucleation temperature and residence time in the freeze-concentrate on in-process and 
storage stability of representative proteins, intravenous immunoglobulin (IVIG), and 
recombinant human serum albumin (rHSA). In addition to stability, characteristics of the 
final solid including morphology and porous structure were characterized at various 
freezing conditions using the polymer encapsulation method, mercury intrusion 
porosimetry method and specific surface area measurements. The findings suggest that it 
is not only the ice nucleation temperature, but also the thermal history post ice nucleation 
that define the surface area of ice and the porous structure of the freeze-dried cake. 
Soluble aggregation of IVIG and rHSA formulations was assessed from size exclusion 
chromatography (SEC). Subvisible particulate formation was determined using 
Microflow imaging (MFI) and FlowCam. A trend of better stability of IVIG and rHSA 
with regard to soluble aggregation was observed when ice nucleation was controlled at -
5°C compared to -12°C. The results suggest that controlled nucleation has the potential to 
minimize degradation of protein pharmaceuticals, which are labile at ice/aqueous 
interface. Apart from the ice nucleation step, the present study identified the residence 
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time in the freeze-concentrate as the critical factor that influences protein stability post 
ice nucleation. A long residence time in the freeze-concentrate, at a temperature where 
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Introduction 
Therapeutic proteins are generally freeze-dried to improve their chemical and/or 
physical stability when they are insufficiently stable in solution for commercial 
distribution and storage. However, the freeze-drying process itself stresses protein 
molecules. In particular, during freezing, protein may adsorb on to the interface between 
the growing ice and the freeze-concentrate suffering an alteration in conformation. Also 
during freezing, the concentration of the solutes increases as water is removed to form 
ice, resulting in a system with higher viscosity but increased reaction rate for bimolecular 
reactions until it approaches the glassy state. Whatever the mechanism, the freezing step 
alone has been reported to cause protein structural perturbation, aggregation or loss of 
activity 1-9.  
The freezing step starts with ice nucleation and rapid growth of a portion of the 
ice until the temperature of the slush reaches the equilibrium freezing point of the 
remaining freeze concentrate; as the shelf of the freeze-dryer is cooled, there is continued 
crystallization of ice until the freeze-concentrate reaches its glass transition temperature.  
There exists natural variation in the temperature at which ice nucleates, producing 
variation in product thermal history.  The variation in product thermal history is due not 
only to the variation in the ice nucleation temperature, but also from additional heating 
from a neighboring vial that undergoes ice nucleation at a later time. To reduce the 
variation in freezing for both process economic and product quality reasons, controlling 
the ice nucleation step has gained increasing attention and was recently listed as an 
example of an emerging technology by the FDA emerging technology team 10. With the 
recognition and emphasis in adopting such innovative technologies, one might expect that 
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controlled ice nucleation technology will be routinely implemented in pharmaceutical 
manufacturing in the near future. Control of ice nucleation at higher temperatures can 
improve process economics and product quality; it leads to increased drying rate 11-15 and 
improved protein stability 7,16. Moreover, improvement in homogeneity of specific 
surface area (SSA), drying rate, and residual moisture by controlled ice nucleation was 
recently critically reviewed 17. Using a controlled ice nucleation technique to synchronize 
the nucleation of ice in all vials within a batch, inter-vial protein stability has recently 
been shown to become better and more uniform 16. The individual contribution of each 
freezing stress (i.e., ice formulation, solute concentration, temperature, and time) on LDH 
activity was investigated and the ice formation was found to be the dominant factor for 
irreversible degradation of LDH 2. Rather than typical glass vials and process conditions, 
the study used a temperature-step approach, where 5 µg/mL of LDH solutions were 
frozen by seeding in hemi-spherical wells in a thermally conductive slab to achieve very 
rapid cooling. With controlled ice nucleation technology, it is now possible to study the 
stresses post ice nucleation in more practical freeze-drying conditions.  
As ice is formed, the concentration of the solutes (i.e. protein, or any potential 
reactant) increases in the regions between the growing ice crystals. Because of the freeze 
concentration and reduction in temperature, viscosity increases until it reaches the glassy 
state in amorphous systems. Ice crystal size and residence time in the freeze-concentrate 
have been proposed as factors of protein degradation post ice nucleation 18. The effect of 
isothermal hold and shelf ramp rate post ice nucleation on ice crystal size and whether 
these variables can have an impact on protein stability was discussed theoretically 17; 
however, there were no data supporting their speculations.  In one case, the rate of a 
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bimolecular reaction in a small amount of drug in 3% sucrose was calculated 
theoretically assuming the activation energy is 20 kJ/mol (chapter 8, page 198-232) 18. 
Despite the Arrhenius effect of low temperatures during freezing, the reaction rate 
increased about one order of magnitude whether the degradation reaction was completely 
uncoupled or coupled (i.e. diffusion-controlled) to the system viscosity 19.  In another 
example, the stability of polyplex particles during freezing was investigated by varying 
the ice nucleation temperature and shelf ramp rate after the ice nucleation step 20. 
Aggregation of the polyplex particles was found to arise from significant residence time 
in the partially frozen system, when the freeze-concentration increased greatly but still in 
a low viscosity state. In that study, a residence time was defined as the time from the ice 
nucleation event to the point when the system reached the maximum freeze-
concentration, around Tg’. The concept of residence times can be extended to the study of 
protein formulations. During that residence time above Tg’, ice crystals continue grow to 
larger size and may have the opportunity to remodel to lower a specific surface area, 
potentially reducing protein adsorption at the ice/freeze-concentrate interface. At the 
same time, however, increased residence time in the increasing concentration of the 
remaining solution where bimolecular reaction rates are higher may produce protein 
aggregation. Little experimental work exists in the literature to explore the contributions 
of these mechanisms in protein systems and identify the critical factors after the initial ice 
nucleation that affect protein stability.  
Few controlled ice nucleation reports have focused on protein stability 7,16; and 
very little information is available on controlled nucleation’s effect on the stability of 
proteins formulated with excipients. We are not aware of any studies that systematically 
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investigate the impact of residence time post ice nucleation on protein stability. In 
addition to studying the effect of controlling ice nucleation on protein stability, the 
present work has a focus on the impact of the freezing protocol post ice nucleation (i.e. 
shelf ramp rate, holding time, etc.) on protein stability. Several representative protein 
systems were studied, recombinant human serum albumin (rHSA) and intravenous 
immunoglobulin (IVIG), both formulated with a commonly used stabilizer, sucrose.  
In addition to the effect of freezing protocols on protein stability, the ice 
nucleation temperature and the sample thermal history post ice nucleation can also affect 
the morphology and porous structure of the final freeze-dried product. The morphology 
and porous structure of the freeze-dried product are important characteristics, which has 
been reported to affect process time 12,21 and influence critical quality attributes such as 
residual moisture level and reconstitution time 22 (and Kulkarni et al., unpublished). 
Several methods have been reported to characterize the microstructure of freeze-dried 
products 23-25. Scanning electron microscopy (SEM) is qualitative and requires cakes to 
be removed from glass vials for analysis. The fragile cakes often break upon removal, 
and thus may not be representative of the entire cake structure. Therefore, novel methods 
are needed to characterize the morphology of freeze-dried product, which allow 
visualization of structural details without breaking the cake apart. A polymer 
encapsulation method 24 helps maintain the intact cake upon removal and allows a cross-
section view, thereby providing qualitative information on ice morphology. Low-pressure 
mercury intrusion porosimetry (LP-MIP) has recently been adapted to provide the pore 
size distribution of intact freeze-dried cakes (Kulkarni et al., unpublished). In the present 
study, the porous structure of the freeze-dried samples frozen under various conditions 
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(i.e. ice nucleation temperature and ramp rate post ice nucleation) were characterized 
using the polymer encapsulation method, LP-MIP method, as well as SSA measurement 
by Brunauer, Emmett and Teller (BET) analysis. 
 
Materials and Methods 
Sample preparation   
Ultrapure rHSA (>99%, 5% (w/v), Albumin Bioscience, Huntsville, AL) and 
lyophilized IVIG (Gammagard®, Baxter, Bloomington, IL) were dialyzed against 5 mM 
potassium phosphate buffer (pH 7.0) with a 10K MWCO membrane at 4°C twice for 3 
hours and a third time overnight. The concentration of protein after dialysis was 
determined by absorbance at 280 nm (Cary Bio100, Varian Inc., Palo Alto, CA) using 
extinction coefficients for rHSA and IVIG of 0.58 mL/mg-cm 26 and 1.36 mL/mg-cm 27, 
respectively.  The dialyzed protein was formulated with or without sucrose at w/w ratios 
from 1:1 to 1:50. For the study of the effect of ice nucleation temperature on protein 
stability, proteins were formulated at 1 mg/mL. For all the post ice nucleation studies (by 
varying the ramp rate, or holding time), proteins were formulated at 3 mg/mL. Aliquots 
(1 mL) of the formulated protein were filled into 5 mL glass tubing vials, which were 
partially stoppered with Daikyo Fluorotec stoppers (West Pharmaceutical Services, West 
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Lyophilization cycle 
Vials with protein solutions were placed on the center of the shelf of a lab freeze-
dryer (LyoStar 3, SP Scientific, Gardiner, NY) surrounded by vials with 5% (w/v) 
sucrose solution to avoid additional radiation heat transfer from the edge and front of the 
chamber, and to ensure comparable product temperatures among vials containing the 
same formulation. Product temperature was monitored with a thermocouple glued with 
heat sink silicone grease (Chemplex 1381, FUCHS lubricants, Harvey, IL) and Kapton 
tape (Cole-Parmer, Vernon Hills, IL) to the outside of selected vials (2 thermocouples per 
formulation) near the vial bottom.  
Control of ice nucleation temperature 
Samples were cooled at a shelf ramp rate of 1°C/min to 5°C and equilibrated for 
30 min, followed by cooling to the target temperature for ice nucleation (i.e., -5°C or -
12°C). Pressurization/depressurization technology (ControLyoTM, SP Scientific, 
Gardiner, NY) was used to control ice nucleation at a fixed time and shelf temperature. 
For the study of the effect of ice nucleation temperature, the shelf was immediately 
cooled post nucleation at 1°C/min to -40°C to complete freezing. For the study of 
residence time post ice nucleation, several shelf ramp rates or hold times post ice 
nucleation were employed as described in the following section. 
Ramp rate post ice nucleation 
 After ice nucleation was induced at a shelf temperature of -12°C, the shelf was 
directly cooled to -40°C at a ramp rate of 0.1°C/min, 1.0°C/min, or 2.5°C/min. The ramp 
rate of 2.5°C/min was the fastest well-controlled rate attainable in this unit.  
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Hold time post ice nucleation at temperature above Tg’ 
 Ice nucleation was initiated at a shelf temperature of -12°C. For pure protein 
formulation without stabilizer, the Tg’ was estimated to be -15°C 28. The samples were 
held at -12°C for 3 or 6 hours before being cooled at 1°C/min to -40°C to complete 
freezing.  
Hold temperature post ice nucleation below Tg’ 
 In addition to holding the samples at a temperature just above Tg’ where there is 
sufficient mobility for reactions to occur, selected samples were alternatively held at a 
temperature below Tg’ for 6 hours where mobility is expected to be limited (i.e. -18°C for 
pure protein formulation). For these experiments, ice nucleation was also initiated at -
12°C followed by cooling the samples at 1°C/min to -18°C for 6 hours and then to -40°C 
at the same rate to complete freezing. 
Drying 
For primary drying, the pressure was set to 60 mTorr and the shelf was heated at 
0.5°C /min to -30°C. After the Pirani and capacitance manometer readings converged, the 
shelf temperature was raised at 0.1°C/min to 40°C and held at a pressure of 60 mTorr for 
6 hours. When the vials were stoppered under full vacuum, there was “blow-out” of the 
dried material upon opening the vial for analysis. To avoid this, vials were stoppered 
when vacuum was released to 600 Torr with dry nitrogen to maintain a dry headspace as 
well as a good seal in the vial. 
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Post lyophilization evaluation of protein degradation 
 The freeze-dried samples were reconstituted with 1 mL of water (18 MΩ, distilled 
and deionized, Barnstead™ GenPure™, Thermo Scientific, Waltham, MA). The freeze-
dried samples were stored at 40 or 50°C for 3 months. Soluble aggregates and/or 
subvisible protein particulates were measured immediately after reconstitution as 
described below. 
Soluble aggregation by size exclusion chromatography (SEC) 
The entire volume (1mL) of the protein solution was filtered through a 0.22 µm 
polyvinylidene difluoride (PVDF) low protein binding filter (33mm in diameter) and 50 
µL of each sample were injected onto a column (TSKgelTM G3000SWXL, 7.8 mm x 30 
cm, 5 µm, Tosoh Bioscience, San Francisco, CA) maintained at 25ºC. The mobile phase 
(100 mM sodium phosphate buffer with 0.2 M NaCl at pH 7.0) was delivered at 1.0 
mL/min by an HPLC system (Model 1100, Agilent, Santa Clara, CA). The absorbance of 
the effluent was measured at 280nm (variable wavelength detector, G1315A, Agilent). 
Absorbance data were acquired and analyzed (ChemStation, Agilent). Monomer, dimer, 
higher order aggregate and fragment peaks were identified. Percent soluble aggregate is 
reported as the areas under the dimer and higher order aggregate peaks relative to total 
area of the identified peaks.  
Subvisible particulate measurement 
Microfluidic-assisted single particle analysis (MicroFlow Imaging (MFI); Model 
5100, ProteinSimple, San Jose, CA) and dynamic imaging particle analysis (Model 
PV100, Flowcam, Fluid Imaging Technologies, Scarborough, ME) were used to count 
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protein subvisible particulates. Using MFI, 0.9 mL of sample solution was injected at a 
flow rate of 0.1 mL/min. The particulates with an equivalent circular diameter (ECD) 
from 1 to 100 µm were counted.  Using Flowcam, 0.9 mL of the sample solution was 
injected with flow rate controlled at 0.15 mL/min, and auto image rate at 32 frames/sec 
(dark and light threshold were both set to 15 for particle segmentation). The particulates 
with an equivalent spherical diameter (ESD) from 2 to 100 µm were counted.   
Characterization of Freeze-Dried Cakes 
Specific surface area (SSA) 
        The SSA of freeze-dried 10% (w/v) sucrose and rHSA formulated with 5% (w/v) 
sucrose was determined in triplicate by BET analysis of the gas adsorption isotherm 
method (Flowsorb II 2300, Micromeritics Instrument Corporation, Norcross, GA). The 
instrument was calibrated with 100% krypton before analysis. He-Kr gas mixture (0.10 
mole% krypton) was used to improve sensitivity for samples with low SSA. Sample 
preparation and other experimental conditions were previously described 29.   
Cake morphology characterization using polymer encapsulation method 
 Qualitative morphology of intact cakes of the freeze-dried 10% (w/w) sucrose 
was captured using a method adapted from Patapoff et al 24. The sucrose samples were 
freeze-dried utilizing controlled ice nucleation at a shelf temperature of -5°C or without 
ice nucleation control. Conservative drying conditions used, with primary drying at a 
shelf temperature of -30°C and secondary drying at 40°C, at a chamber pressure of 60 
mTorr. To encapsulate the freeze-dried cakes, silicone (a degassed mixture of vinyl-
terminated polydimethylsiloxane and curing agent [Sylgard184® silicone elastomer kit, 
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Ellsworth, Germantown, WI]) was slowly infused into the intact freeze-dried cakes and 
allowed to crosslink at 40°C for 2 days. The glass vials were easily broken using a 
laboratory press (Carver Inc., Wabash, IN).  Intact cakes encapsulated with the polymer 
were sliced with a custom-made guillotine-like slicer. The sliced cakes were stained with 
a yellow highlighter pen, which fluoresced under UV light for better contrast.  Images 
were captured under a stereo microscope (Model SZ61, Olympus, Center Valley, PA).  
Low pressure mercury intrusion porosimetry (LP-MIP) 
 The average pore size of freeze-dried rHSA samples formulated with 5% (w/v) 
sucrose was determined by mercury intrusion porosimetry (AutoPore IV 9500, 
Micromeritics Instrument Corporation, Norcross, GA). The top of a vial containing intact 
cake was cut off 1.5 cm from the bottom of the vial.  The intact cake together with the 
bottom portion of the vial was placed directly, with no further sample preparation, into a 
15 mL penetrometer with stem volume of 1.13 mL. A low filling pressure (1 psi) and 
optimized pressure increments up to 40 psi were utilized for the analysis as previously 
described (Kulkarni et al., under review).  
 
Statistical analysis 
 Two-way ANOVA was applied to evaluate the significance of the differences in 
protein aggregation due to different freezing protocols (i.e. ice nucleation temperature or 
ramp rate).  
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Results and Discussion 
The ice nucleation temperature has been reported to affect physical stability of 
proteins sensitive to the ice/freeze-concentrate interface, especially for formulations at 
low concentration and/or without stabilizers 4,16,30. In a recent report, higher activity 
recovery and tetramer recovery of LDH after freeze-thawing linearly correlated with 
higher ice nucleation temperature 16. However, controlling ice nucleation at a higher 
temperature (-4°C) did not show vastly superior stability of freeze-dried LDH. In the 
present study, two additional proteins, IVIG and rHSA formulated with and without 
stabilizers were explored to further understand the role of ice nucleation control on 
physical stability of the protein formulations. In addition to controlling the ice nucleation 
temperature, the residence time of the proteins in the freeze concentrate above the Tg’ of 
the formulation was varied. 
 
1. Effect of ice nucleation temperature on protein stability and cake morphology 
IVIG was formulated at 1 mg/mL with or without sucrose at several ratios (1:3, 
1:6, 1:50, w:w). IVIG alone (i.e., without sucrose) was considerably less stable than IVIG 
with sucrose during long-term storage at 40°C. IVIG was more stable when freeze-dried 
using the higher ice nucleation temperature of -5°C than -12°C (two-way ANOVA, p 
≤0.05) (Table 1). The ice nucleation temperature showed marginal impact on the long-
term stability of IVIG formulations with sucrose; there was no significant difference in 
the stability of IVIG in the 1:3 or 1:50 sucrose formulations. It should be noted that the 
stock solution of the protein was ~90% monomer, with the remaining including 
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aggregates and fragments, which might have blurred the ability to determine small, but 
meaningful differences in stability. 
Unlike IVIG, the rHSA used for the present study consisted of >99.5% monomer 
prior to freeze-drying, which was expected to make detection of small changes in purity 
easier. rHSA was formulated at 1 mg/mL with or without sucrose at several ratios (1:1, 
1:6, w:w). As expected, the rHSA formulation alone (without sucrose) showed the most 
soluble aggregation. After freeze-drying, only dimer formation were detected in all 
formulations; on storage at 50°C, higher order aggregates were formed. Stability against 
aggregation increased as the ratio of sucrose increased in the formulation from 1:1 to 1:6 
(rHSA:sucrose, w:w). At each storage time and formulation, there was less aggregation 
when ice nucleation was controlled at -5°C compared to -12°C (Table 2), but the 
difference was not always significant. Ice nucleation at -5°C provided significantly 
greater stability for the rHSA:sucrose 1:1 (w:w) at 1 month and 3 month storage at 50°C 
and for the rHSA:sucrose 1:6 (w:w) immediately after freeze-drying (p≤0.05).  However, 
two-way ANOVA of the entire data set (Table 2) showed significantly better protein 
stability at the ice nucleation temperature of -5°C (p ≤ 0.05).  
The degree of improvement in protein stability from controlling ice nucleation at 
a higher temperature appears to be protein-dependent. In a recent report, a ~8% 
difference in LDH activity was observed after freeze-thaw for a 7°C difference in ice 
nucleation temperature 16. Although the improvement in storage stability of IVIG and 
rHSA formulations at the higher ice nucleation temperature was statistically significant, 
the improvement was small and may not have practical significance, at least from a 
potency viewpoint.  However, at least in principle, even a slightly higher level of protein 
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aggregates may have a higher propensity to stimulate immune response 31. Preliminary 
data showed no increase in soluble aggregation by SEC after freeze-thaw in both IVIG 
and rHSA formulations. The data suggested that the damage on the proteins during the 
process occurred primarily during drying, which is not unusual.  
 The morphology of the freeze-dried product is another characteristic of the final 
solid, which can influence product quality attributes such as residual moisture level 
and/or reconstitution time. The morphology can be affected by the freezing protocol 23. 
Therefore, in addition to investigating the effect of ice nucleation temperature on protein 
stability, the morphology of freeze-dried cakes at various ice nucleation conditions was 
characterized. We find morphology is impacted by both ice nucleation temperature and 
thermal history post nucleation. The lyophilized solid from the 1 mg/mL protein 
formulation was too fragile to use the polymer encapsulation procedure. Instead, the 
morphology of freeze-dried 10% (w/v) sucrose samples was characterized using the 
polymer encapsulation method (Figure 1).  The yellow color in the cross-section of the 
encapsulated cake represents the sucrose material, whereas the black areas correspond to 
the pores within the cake or gap between the glass vial and the cake occupied by the 
polymer. Without controlled ice nucleation, the cake had a finer porous structure, 
corresponding to large number of smaller ice crystals formed by spontaneous ice 
nucleation of -12°C measured by thermocouple during freezing. When ice nucleation was 
controlled at a shelf temperature of -5°C (when the product temperature was -2°C), 
generally larger pores were seen as expected, but also large channels were observed, 
consistent with previously reported faster primary drying at a higher ice nucleation 
temperature 21,32. The SSAs of the cakes (Figure 1) were 0.28 and 0.58 m2/g for the ice 
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nucleation temperatures of -2°C and -12°C, respectively, measured by thermocouple in 
the bottom center of the vial. The SSA of 10% sucrose increases linearly as ice nucleation 
temperature decreases (𝑆𝑆𝐴 = −0.03×𝑇!"#  !"#$%&'()! + 0.26, R2=0.92) (Fang et al., 
under review). When the ice nucleation temperature of the two cakes in Figure 1 were 
fitted in the above equation, the SSAs were found to be 0.32 vs. 0.62 m2/g, very close to 
the experimental values.  
The observation of large channels and pores at a higher ice nucleation temperature 
correlated with a lower SSA, which is expected to improve protein stability 33 by 
reducing protein adsorption at the ice/freeze-concentrate interface.  A 10°C decrease in 
ice nucleation temperature (-12 vs. -2°C) resulted in twice the SSA in the 10% sucrose 
(w/v) samples. Degradation of another protein, hGH, on storage was largely due to 
protein at the surface; that is, nearly all of the degradation occurred in the fraction of 
protein at the surface 33. Therefore, when the SSA of a protein sample is varied due to the 
process conditions (i.e. ice nucleation, cooling rate, annealing, or drying), both physical 
and chemical stability of the protein formulation can be significantly affected, 
particularly for excipient rich formulations. To better understand the surface phenomena 
that contributed to degradation of IVIG during freezing, the fraction of protein on the 
surface of freeze-dried IVIG:sucrose 1:50 (w:w) formulation was studied; this 
formulation provided an excipient-rich system where a significant fraction of the total 
protein is expected to be at the surface. The mass fraction of the protein on the surface 
was calculated from the SSA measurement and % elemental nitrogen determined by X-
ray photoelectron spectroscopy (XPS) analysis of the outermost ~100 Å layer as 
previously described 33. XPS analysis found 0.7% elemental nitrogen (corresponding to 
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protein) in samples prepared using both ice nucleation temperatures. The SSAs of the 
samples were 0.64 ± 0.02 m2/g (-5°C) and 0.90 ± 0.01 m2/g (-12°C), a difference of about 
41%.  Thus, the % protein at the surface is about 3% and 4% for -5°C ice nucleation and -
12°C ice nucleation, respectively. If the degradation rate were directly proportional to the 
fraction of protein at the surface, the rate would be 41% higher for the lower ice 
nucleation temperature. However, it appears that the degradation rates on storage were 
only marginally lower at a higher ice nucleation temperature (Table 1). 
 
 In addition to better average protein stability due to the reduction in SSA at a 
higher ice nucleation temperature, controlling ice nucleation has been shown to improve 
the batch uniformity of protein stability 16 presumably by producing greater vial-to-vial 
uniformity in ice structure. The more uniform ice structure across the batch produces 
more uniform product resistance and therefore more uniform sublimation rates. 
Uniformity of primary drying rates can be seen from process data.  The magnitude of the 
slope of Pirani gauge reading versus time was previously reported to reflect the 
uniformity in drying rate across the batch; a larger slope indicates more uniform drying 7. 
In the present work, the uniformity in drying rate was evaluated with a full shelf of 10% 
(w/v) sucrose solutions freeze-dried under various ice nucleation conditions (Figure 2). 
The magnitude of the slope at the inflection point followed the rank order: -5°C (24 
mTorr/hr) > -8°C (12 mTorr/hr) > -12°C (7 mTorr/hr) ≈ uncontrolled nucleation (6 
mTorr/hr). However, the point where the Pirani signal starts to decrease indicates the 
point at which primary drying is over in approximately 97% of the vials 34. The higher 
slope suggested improved uniformity in drying rate for the remaining 3% vials, not the 
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entire batch. The reason why a lower slope was observed when controlling ice nucleation 
at lower temperatures (-8°C and -12°C) compared to -5°C was not clear. If, as has been 
proposed, the uniformity in drying rate is due to the uniformity in SSA from vial-to-vial, 
such an improvement in slope should also be accompanied by more uniformity in protein 
stability across the batch.   
 The above results show that controlled nucleation at a higher temperature 
improves the storage stability of the two model proteins investigated here, which is 
consistent with previous reports 7,16.  Furthermore, the data on the slope of the Pirani 
gauge reading with time suggests that controlling ice nucleation at higher temperatures 
should improve the uniformity of protein stability as was demonstrated in an earlier 
report 16. However, ice nucleation control only controls the first step in freezing.  The 
completion of freezing occurs during the ramp down to below the glass transition 
temperature of the freeze concentrate. The effects of the ramp rate and isothermal hold 
after ice nucleation on protein stability are less well understood. In the next section, shelf 
ramp rate and the holding duration and temperature were varied to identify the critical 
factors for protein stability.  
 
2. Effect of residence time (post ice nucleation) on protein aggregation 
 After ice nucleation, crystal growth continues as the shelf cools the vial contents. 
On cooling the shelf, the dendritic ice often formed during the nucleation step 35 may 
have the opportunity to re-crystallize, resulting in fewer, but larger crystals, leading to 
smaller SSA; conversion to smaller SSA is expected to occur more at slower cooling 
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rates 23. The smaller SSA should yield better protein stability due to reduced adsorption at 
the ice/freeze-concentrate interface. On the other hand, on cooling the shelf, the solutes 
(i.e. buffer components, excipients, and proteins) become more concentrated as water 
leaves the solution to form ice. In the remaining freeze-concentrated solution, the rate of 
bimolecular reactions, such as protein aggregation, is expected to increase, at least until 
the freeze-concentrate reaches a glassy state in which mobility is sufficiently low 36 to 
slow the rate of reactions.  
Slow cooling increases the time in which the protein is in this more reactive 
freeze-concentrated state above its glass transition temperature, Tg’.  Thus, while slow 
cooling is expected to decrease the surface area of ice to which protein can adsorb and 
unfold, the slower rate is also expected to increase the time in which the protein resides in 
the reactive freeze-concentrate. Therefore, slow cooling provides at least these two 
opportunities for protecting or destabilizing the protein. Conversely, rapid freezing would 
destabilize by producing a higher ice surface area for protein adsorption, but reduce the 
time of residence in the reactive environment of the freeze-concentrate.  Here, we define 
the residence time as the time from ice nucleation to when the product temperature 
reaches Tg’. To investigate the contributions of ice surface area and residence time to 
protein stability, the shelf ramp rate post ice nucleation or the holding temperature and 
duration were varied.  
2.1 Effect of ramp rates post ice nucleation on ice crystal size and protein aggregation 
 rHSA:sucrose 3:50 (w:w) cooled at the slow rate of 0.1°C/min produced cakes 
with a large average pore size of 39 µm; with a size range of 28 - 60 µm corresponding to 
10% to 90% of the total volume of mercury that was intruded into the sample. Cooling at 
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2.5°C/min produced a much smaller pore size  (30 µm; range of 22 - 48 µm), even though 
both were nucleated at -12°C (Table 3). The larger pore size in the freeze-dried samples 
correlated with a lower SSA when cooled at a slower rate  (Table 3). About 19% 
reduction in SSA was observed when the cooling rate decreased from 2.5 to 0.1°C/min. 
Thus, it is not only the ice nucleation temperature, but also the ramp rate post ice 
nucleation that defines the SSA of ice and the size of pores in the freeze-dried cake.  
Freeze-thawing did not produce soluble aggregates in either rHSA (3 m/mL) 
alone or rHSA:sucrose 3:50 (w:w) (data not shown). Additionally, storage for 3 months 
at 40°C did not produce soluble aggregates in lyophilized rHSA:sucrose 3:50 (w:w) 
(Table 4). However, lyophilized rHSA alone showed an increase in protein aggregation 
during freeze-drying as well as during storage (Table 4).  Though the residence time of 
rHSA in the freeze-concentrate was twice as long (25 versus 12 min) at the lowest shelf 
ramp rate of 0.1°C/min versus at 2.5°C/min, there was no significant difference in protein 
soluble aggregation using these two ramp rates. The SSA was reduced by 19% at a 
slower ramp rate (0.1 vs. 2.5°C/min). Thus, the lack of difference in protein aggregation 
between the two ramp rates could be due to the longer residence time at the slower ramp 
rate that cancelled the stabilization effect arising from the reduction in SSA.  
It is possible that protein aggregates larger than the soluble aggregates are 
sensitive to the cooling rate even when soluble aggregation is not. In a previous study, no 
soluble aggregation of IgG was observed either after freeze-thawing or after freeze-
drying; however larger insoluble aggregates were detected after freeze-drying 9. More 
insoluble protein aggregates were reported at a much faster cooling rate (i.e. quench 
cooling in liquid nitrogen) than slow cooling at 2°C/min in the example of IgG 9, and  the 
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same observation was made for hGH 37 comparing cooling rates of 0.5 and 50°C/min 
after freeze-drying. In summary, insoluble aggregation of protein (i.e., subvisible 
aggregates) was reported to be influenced by the freezing conditions. 
In the present work, the IVIG samples were pulled out of the freeze-dryer using a 
sample-thief after freezing, primary drying or secondary drying. Subvisible particulate 
formation was analyzed with MFI in the pre-lyo solutions, thawed, and reconstituted 
solutions at various stages of freeze-drying. There was little increase in subvisible 
particulates in the samples after freeze-thawing or primary drying, whereas significant 
subvisible particulates formed during secondary drying (Figure 3). It could be that 
proteins are susceptible to elevated temperature in secondary drying, at least when the 
moisture content is relatively high. Another possible explanation is that proteins generally 
exhibit best stability at intermediate level of moisture 38; therefore, more degradation is 
expected near the end of secondary drying when the sample has low moisture but still 
sufficient mobility exists to allow unfolding. Examples of optimal protein stability have 
been reported at intermediate moisture content (≈ 2-4%) in both pure protein and proteins 
formulated with disaccharides 39-41. However, one must also recognize that the additional 
stability at intermediate water content, relative to zero water content, was quite small, so 
other effects may be driving the instability. 
Based on the observation of significant increase in subvisible protein particulates 
after freeze-drying in IVIG, lyophilized rHSA formulations were similarly analyzed 
using Flowcam at the two ramp rates, 2.5°C/min or 0.1°C/min (Figure 4). There was an 
increase in subvisible particulates after freeze-drying compared to after freeze-thawing 
both in the presence and absence of sucrose. The presence of sucrose stabilized the 
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protein against forming subvisible aggregates relative to rHSA alone. There was a 
reduction in subvisible particulate formation in those samples cooled at 2.5°C/min 
compared to 0.1°C/min, but this difference is not statistically significant due to the large 
variability in particle counts.  However, the consistent higher particle levels after drying 
compared to after freeze-thaw (p<0.05) and the consistent higher particle levels with the 
slower ramp (p<0.3) suggest the trends may be real. 
When the shelf ramp rate was slowed from 2.5°C/min to 0.1°C/min after ice 
nucleation, the SSA and pore size indicates that ice crystals were substantially larger 
and/or smoother, reducing the ice/freeze-concentrate interface where proteins can adsorb 
and unfold. On the other hand, the residence time for the rHSA formulation without 
excipients increased from 12 minutes to 25 minutes, which potentially promotes protein 
aggregation due to the longer residence time in the freeze-concentrate. However, it must 
be acknowledged that only a narrow range of residence time (both within 25 minutes 
when the shelf ramp rate varied from 0.1 to 2.5°C/min) was evaluated and there may not 
have been a sufficiently different residence time to produce a measureable difference in 
either soluble or insoluble aggregates.  To further explore the possible effect of residence 
time, much longer residence times were investigated, and these results are discussed in 
the following section.  
2.2 Effect of holding time post ice nucleation on protein aggregation 
For pure rHSA (3 mg/mL) without stabilizers, the residence time in the freeze 
concentrate until Tg’ was reached increased from 12 minutes to 18 minutes to 25 minutes 
when the shelf ramp rate decreased from 2.5°C/min to 1°C/min or 0.1°C/min.  The level 
of soluble aggregation was comparable within this wide range of ramp rates (Figure 5). 
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Only dimers were detected by SEC in the reconstituted rHSA samples after freeze-
drying. Generally, the Tg’ of a frozen solution can be measured with modulated 
differential scanning calorimetry (MDSC). However, it is difficult to measure Tg’ for the 
freeze-concentrate of a pure protein because the transition is not sufficiently strong or 
sharp enough to detect even at high protein concentrations >50 mg/mL 28. In the absence 
of a measured Tg’ for rHSA, the Tg’ was estimated to be -15°C 28.   rHSA was held at -
12°C for 3 hours or 6 hours to determine the effect of a long residence time above Tg’ on 
protein stability. Soluble aggregation increased from 1.26% aggregates when the sample 
was held for 3 hours to 1.90% for a 6-hour hold at -12°C; both were significantly higher 
than the level of soluble aggregates (0.90%) when the residence time was less than 30 
minutes at the various ramp rates (Figure 5). The level of soluble aggregate linearly 
correlated with the residence time in the freeze-concentrate (R2=0.97, Figure 5). 
Although the residence time during a wide range of practical cooling rates used during 
freeze-drying does not differ sufficiently to have stability consequences, the hold time 
experiments show a role for residence times as a factor in protein stability if for some 
reason, unusually long holding times were used. Indeed, long times are used when 
annealing the frozen material between the Tg’ and the onset temperature of ice melt. 
However, such annealing procedures are normally only used with proteins formulated 
with stabilizers. 
 
2.3 Effect of holding temperature post ice nucleation on protein aggregation 
As the samples continue to cool to temperatures near and then below Tg’, 
viscosity and freeze-concentration increases to maximum until it reaches a glassy state. 
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Less soluble aggregate is expected when held at temperatures below Tg’ compared to 
temperatures above Tg’ for the same holding duration, since mobility is reduced in a 
glassy state. To test this expectation, pure rHSA was cooled at 1°C/min post ice 
nucleation to -18°C (i.e., below Tg’), and held for 6 hours followed by cooling the shelf 
to -40°C to complete freezing. Much less soluble aggregation was found in rHSA when 
held for 6 hours at -18°C (1.13%) compared to at -12°C (1.90%) (Figure 6). We note that 
here the time calculated from the ice nucleation event to when the product temperature 
reached Tg’ (-15°C) was only about 20 minutes.  
The data in the present study showed an increase in aggregation of rHSA at a long 
holding time at a temperature above Tg’. It is not just the time that the proteins are 
exposed to in the freeze-concentrate, but rather the freeze-concentration accompanied by 
ice formation, the temperature at which the system is highly mobile for reactions to 
occur, and the residence time in the mobile, more concentrated environment that together 
determine protein degradation post ice nucleation. Cautions are needed in designing a 
freezing process post nucleation. Protein aggregation was not affected within normal 
ramp rates (i.e. 0.1-2.5°C/min); however, a long holding time post ice nucleation at 
temperatures above Tg’ does increase degradation and therefore is not desirable. In the 
case of bulk freezing of active pharmaceutical ingredients (normally pure proteins) for 
storage and transportation, the freezing time can be as long as 17 hours in a 10 liter 
container 42. The findings in the present study addressed the effect of residence time in 
the freeze-concentrate on protein aggregation and the results are directly relevant to 
process design in bulk freezing and thawing. 
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Summary and Conclusions 
In the present work, ControLyo™ was used to study the effect of ice nucleation 
temperature, and residence time in the freeze-concentrate on aggregation of the protein 
formulations after freeze-drying. Two proteins, rHSA and IVIG, formulated in various 
ratios with sucrose were studied. In addition to stability, characteristics of the freeze-
dried samples including morphology and porous structure of intact cakes were 
characterized using polymer encapsulation and mercury intrusion porosimetry methods at 
various freezing conditions. When ice nucleation was controlled at a higher shelf 
temperature (i.e. -5°C) compared to spontaneous ice nucleation, not only larger pores but 
also large channels were observed in the 10% sucrose sample, consistent with a reduced 
ice surface area which potentially reduces protein adsorption. Average pore size 
determined by LP-MIP correlated well with SSA of the freeze-dried samples. Larger pore 
size was found at a slower ramp rate (0.1 vs. 2.5°C/min) even though both were 
nucleated at -12°C. Thus, it is not only the ice nucleation temperature, but also the 
thermal history post ice nucleation that define the SSA of ice and the size of pores in the 
freeze-dried cake. There was a trend of better protein stability (i.e. less aggregation) at a 
higher ice nucleation temperature (-5 vs. -12°C) in both proteins. One may expect more 
degradation in manufacturing in nominally the same process as run in the lab since the 
ice nucleation temperature in manufacturing appears to be about 10°C lower than in the 
lab.  Efforts to reduce ice surface area by controlling ice nucleation at a higher 
temperature may not be as beneficial for proteins that are stable during freezing or when 
formulated at a much higher concentration such as with monoclonal antibody 
formulations. Of course, the advantages of faster primary drying would still apply.  Apart 
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from the ice nucleation step, the present study suggested the residence time in the freeze-
concentrate post ice nucleation can be a critical factor for protein stability. A long 
residence time in the freeze-concentrate, at a temperature where enough mobility exists 
(i.e. above Tg’ of the formulation) may result in significant protein aggregation.  
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Table 1. % Degradation (formation of soluble aggregates and fragments) determined by 
SEC in IVIG after freeze-drying (0 month) and storage for 1 and 3 months at 40°C. The 
concentration of IVIG was 1 mg/mL in all formulations. The samples were freeze-dried 












0 1 3 0 1 
  
0 1 3 0 1 3 
            
CN-5°C 10.6 26.9 29.5 10.3 13.9 
  
11.3 11.9 13.9 10.5 12.0 13.2 
SE 0.4 0.9 0 0.2 0.1 
  
0.4 0.2 0.1 0 0.5 0.1 
CN-12°C 11.4 28.6 31.7 11.6 13.7 
  
11.3 12.5 13.8 11.9 12.6 13.2 
SE 0.1 0.3 0.2 0.2 0.1 
  






















Table 2. % Soluble aggregation determined by SEC in rHSA after freeze-drying (0 
month) and storage for 1 and 3 months at 50°C. The concentration of rHSA was 1 mg/mL 
in all formulations. The samples were freeze-dried with controlled ice nucleation (CN) at 




rHSA rHSA:sucrose 1:1 (w:w) rHSA:sucrose 1:6 (w:w) 
Storage (month) 
0 1 3 0 1 3 0 1 3 
CN-5°C 1.10 25.03 42.95 0.78 8.06 16.00 0.44 0.98 2.63 
SE 0.04 0.40 0.25 0.05 0.03 0.20 0.05 0.04 0.10 
CN-12°C 1.12 25.29 43.40 0.82 8.65 17.78 0.59 1.14 2.90 


























Table 3. Pore size (by MIP) and SSA (by BET) in rHSA samples formulated with 5% 
sucrose.  
Freezing condition Pore size (µm) SSA (m2/g), 
Average ± SE Average ± SE Range (corresponding to 




30 ± 0 48 - 22 1.08 ± 0.05 
CN-12°C, 
0.1°C/min 































Table 4. % Soluble aggregation in reconstituted rHSA solutions, rHSA alone or 
rHSA:sucrose 3:50 (w:w) after freeze-drying (time 0) and storage for 1 and 3 months at 
40°C. The concentration of rHSA was 3 mg/mL in each formulation. Ice nucleation was 
initiated at -12°C using ControLyo™ in all experiments. The shelf cooling rate post ice 
nucleation was controlled at 2.5°C/min or 0.1°C/min.  
 
 Ramp rate 
(°C/min) 
rHSA rHSA:sucrose 3:50 (w:w) 
Storage (month) 
  0 1 3 0 1 3 
       
2.5  0.96 11.90 21.06 0.43 0.43 0.44 
SE 0.02 0.17 0.12 0.02 0.00 0.02 
0.1  0.90 12.35 21.21 0.49 0.45 0.47 
SE 0.02 0.54 0.14 0.02 0.01 0.01 


























Figure 1. Morphology of 10% (w/v) sucrose cakes freeze-dried without nucleation 
control (left), and with controlled ice nucleation at a shelf temperature of -5°C (right). 
Both cakes were from vials located on the edge of the shelf. The product ice nucleation 
temperatures from thermocouple measurement were -12°C (left), and -2°C (right). The 




























Figure 2. The pressure profile sensed by the Pirani gauge and the capacitance manometer 
(CM). One full tray (total 264 vials) of 10% sucrose solutions (5 mL fill in 10 mL vial) 
were freeze-dried under four different conditions, controlled ice nucleation at shelf 
temperature -5, -8, and -12°C and uncontrolled ice nucleation (UCN) (from right to left in 
the figure), respectively. To determine the slope (1st derivative) of the Pirani profile with 
time, the Pirani readings were smoothed from the data collected every 30 seconds. The 
magnitude of the slope at the inflection point followed the rank order: -5°C (24 mTorr/hr) 




















Figure 3. Subvisible particulate formation in IVIG solutions (1 mg/mL) measured with 
MFI. The samples were removed from the freeze-dryer after freezing, primary drying or 
secondary drying. 
 





















Figure 4. Subvisible particulate formation in rHSA formulations (rHSA alone, or 
rHSA:sucrose (3:50)) measured with Flowcam. The samples were analyzed after freeze-
thaw or reconstitution of the freeze-dried samples. Ice nucleation was initiated at -12°C 
using ControLyo™ in all experiments. The shelf cooling rate post ice nucleation was 





















Figure 5. % Soluble aggregation of rHSA (3 mg/mL) measured with SEC as a function of 
residence time at various process conditions (indicated on the left). The data was fitted to 
a linear function (R2 = 0.97, indicated on the right). In all experiments, ice nucleation was 
controlled at a shelf temperature of -12°C. Shelf ramp rate post ice nucleation varied 
from 2.5°C/min to 1, or 0.1°C/min. The residence time in the freeze-concentrate was 
calculated from when ice nucleated to when the product temperature reached -12°C (Tg’ 




















Figure 6. % Soluble aggregation of rHSA (3 mg/mL) measured with SEC for a 6-hour 
hold at -12°C or -18°C (Tg’ of pure rHSA was estimated to be -15°C). In all experiments, 
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Chapter 4 
Distribution of Ice Nucleation Temperature in a Batch and Its Implication on 
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Abstract 
Existing methods have been used to determine average product resistance (Rp) 
during primary drying across a batch. However, little work has been done to address the 
distribution in Rp at various locations on the shelf. The objective of this study was to 
determine Rp in 10% (w/v) sucrose samples placed on the edge and center of the shelf. A 
location-dependent ice nucleation temperature was observed with highest ice nucleation 
temperature in the samples on the left edge of the shelf followed by comparable ice 
nucleation temperatures in the right edge and center vials. Product resistance in 
individual vials was calculated utilizing the cycle data, namely, the “direct vial” method. 
The challenges in this method were addressed. Finally, correlations were established 
between the product resistance calculated in the center vials with reliable Kv values and 
the corresponding specific surface area (SSA) or the ice nucleation temperature. The 
established correlations were further used to estimate Rp in edge vials with known ice 
nucleation temperature or SSA. The data suggested Rp is lower in the edge vials due to a 
higher ice nucleation temperature. The findings provide insights into developing methods 
to accurately measure Rp in individual vials.    
 
Keywords: 
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Introduction 
During the primary drying phase of lyophilization, water vapor passes through the 
porous partially dried layer, experiencing a resistance to mass flow, the so-called product 
resistance (Rp). Early in primary drying, Rp is low, and ice sublimation rate is at its 
maximum. This presents a high mass load for the freeze-dryer, but the product 
temperature is usually lower due to the heat removed by sublimation. Later in primary 
drying, the dried layer thickness increases, producing higher resistance to vapor flow, 
which results in lower sublimation rate and higher product temperature. Improved 
characterization of the Rp throughout primary drying would aid optimization of process 
efficiency while maintaining product temperature below any critical value.  Existing 
methods to determine product resistance include Manometric Temperature Measurement 
(MTM) 1,2, utilization of mass flux from Tunable Diode Laser Absorption Spectroscopy 
(TDLAS) 3, utilization of heat flux from the heat sensors adhered on the shelf surface; 
however, these approaches measure a batch average Rp. One may also estimate product 
resistance for product in a given vial from the time dependence of product temperature in 
primary drying, as long as the vial heat transfer coefficient is known or can be reliably 
estimated from the cycle data. This is the method we employ in this work to obtain the 
resistance for product in a given vial, which is a simplified version of the Kuu procedure 
4.   Little is known about any differences in Rp based on vial location, i.e., between center 
and edge vials, contrary to the well known edge vial effect for the heat transfer 
coefficient (Kv) 5. In the present study, the objective was to quantify any difference in 
product resistance between center and edge vials.  
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Theoretical calculation of Rp: 
The resistance provided by the partially dried cake to flow of water vapor from 
the sublimation front below, 𝑅!, (area normalized resistance) can be calculated from the 
ice sublimation rate, 𝑚, and the difference between the vapor pressure of ice at the 
sublimation interface (P0) and the controlled chamber pressure, Pc. (Eqn 1). Either a time-
averaged 𝑅! or Rp (t) as a function of time or dry layer thickness can be determined.  
 
 𝑅! = 𝐴!
𝑃! − 𝑃!
𝑚    
Eqn 1 
 
Calculation of time-averaged product resistance, 𝑅! 
To obtain a time-averaged 𝑅!, the average sublimation rate, 𝑚, can be determined 
experimentally from the measured mass loss of water, 𝑚!!!, within a defined time 
period. Alternatively, a time-averaged sublimation rate, 𝑚 (Eqn 2), can also be found by 
dividing the theoretical mass of water lost, 𝑚!!!, (Eqn 3) by the time of sublimation, ∆t, 
taken as the time from the start to the end of primary drying. Assuming ice sublimation 
from the cylindrical frozen solution is radially and angularly symmetric, the sudden 
increase in product temperature (Figure 1), measured at the bottom center of the vial 




∆𝑡    Eqn 2 
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The theoretical mass of water lost by sublimation during primary drying can be 
calculated from the solute concentration, c (w/w), the fill volume, 𝑉!"##, and the density of 
the solution, 𝜌!"#$. The remaining amorphous solute, sucrose, retains unfrozen water at 
the level of 22% (or 0.18 g of water for each 1 g of sucrose freeze-concentrate) 6-8; 
however, about ½ of the unfrozen water has been removed by the end of primary drying 
due to early secondary drying. The amount of water lost by the end of primary drying can 
then be found from Eqn 3. 
 
 𝑚!!! = 𝑉!"##𝜌!"#$(1− 1.1  𝑐) Eqn 3 
  
Calculation of product resistance as a function of time, Rp (t) 
Product resistance as a function of time, Rp (t) can be obtained from a real-time 
measurement of sublimation rate over time, 𝑚(𝑡). TDLAS is commonly used to 
determine real-time ice sublimation rates; however, it measures a batch-average 𝑚 𝑡  
rather than in individual vials. Alternatively, a “direct vial” method can be used to 
calculate real-time sublimation rate. This method utilizes the process data directly 
obtained from the freeze-drying process (i.e., Pc, Ts, Tp); the step-by-step calculation to 
determine Rp (t) in individual vials is explained in the Methods. 
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The sublimation rate,  𝑚, is related to the rate of heat loss due to sublimation, 𝑞, 
by the enthalpy of sublimation, Δ𝐻! (Eqn 4). The rate of heat loss can similarly be an 





 Eqn 4 
Due to the quasi-steady state nature of heat flow during primary drying, the heat 
flow out of the vial due to sublimation can be equated to the heat flow into the vial 
primarily from the shelf to the frozen solution. A vial heat transfer coefficient, Kv, is used 
to relate the heat flow into the vial from the shelf at a temperature, Ts, to the inside 
bottom of the vial where the frozen product is at a temperature, Tp (Eqn 5), 
 
 𝑞 = 𝐴!𝐾! 𝑇! − 𝑇!  Eqn 5 
where 𝐴! is the cross-sectional area of the vial parallel with the shelf. Combination of 
Eqn 4 and 5 leads to an expression for sublimation rate, 𝑚, in terms of the difference in 








Equation 6 provides another means of finding the real-time sublimation rate provided that 
the value of 𝐾! is accurate. 
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Combination of Eqn 4 - 6 and rearrangement yields Eqn 7, providing the basis of 
determining Rp, which is calculated from dimensions of the vial (Av, Ap,), Kv, the freeze-
drying process condition (Ts, Pc), the temperature response of the product (Tp), and the 




𝐴!𝐾! 𝑇! − 𝑇!
 Eqn 7 
Methods 
Sample preparation and lyophilization process: 
Solutions (10% w/v sucrose) were filtered through 0.22µm filter and filled (2 mL) 
into 10 mL tubing vials, which were partially stoppered with 20 mm two-legged stoppers. 
A full tray of vials was loaded onto the bottom shelf of a lab freeze-dryer (Lyostar 3 with 
ControLyo™, SP Scientific, Stone Ridge, NY). Product temperature (Tp) was monitored 
with 11 thermocouples placed in the bottom center of vials; 3 thermocouples each in vials 
touching the band on the left and right edges, and 5 thermocouples were placed in vials in 
the center of the shelf. The temperature of shelf surfaces nearest to the inlet and outlet of 
heat transfer fluid, as well as the temperature of the band used to hold the vials in place 
were monitored with thermocouples.  
The solutions were frozen without ice nucleation control or using controlled ice 
nucleation at shelf temperatures of -5 and -8°C. For primary drying, the chamber pressure 
(Pc) was 60 mTorr and the shelf temperature (Ts) was raised at 0.5°C/min to -30°C where 
it was held for primary drying. When the Pirani gauge reading converged with the 
capacitance manometer reading, the shelf temperature was raised at 0.2°C/min to 50°C 
and held for 2 hours at a chamber pressure of 60 mTorr.  
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The specific surface areas of the freeze-dried samples were measured by BET 
analysis of gas adsorption as previously described 9. 
Calculation of Rp in individual vials: 
 Eqn 6 provided the basis for determining Rp from the sublimation rate using the 
“direct vial” method 10. Using this method, Kv and P0 are the only two items that need to 
be calculated and the calculation is explained from Eqn 8 to 16. 
Determination of Kv: 
Accurate calculation of individual vial real-time Rp (t) from measurement of 𝑚 
(Eqn 6) requires an accurate value of Kv, which can be calculated from Eqn 8.  Note that 
Eqn 8 is a rearrangement of Eqn 6, which has been averaged over the entire primary 
drying time. Classically, Kv is calculated from gravimetrically determined values of 𝑚 in 
additional runs using pure ice in place of the product at the same shelf temperature and 
chamber pressure as previously described 11. When ice is used in place of product, the 
value of Tp does not change significantly with time.  However, when using the product 
itself rather than pure ice, the product temperature (Tp) changes with time due to the 
resistance built up from the partially dried layer. Thus, when using the “direct vial” 
method to determine Kv of each vial containing a thermocouple (Eqn 8),  𝑚  (Eqn 2) is the 
theoretical amount of water (from Eqn 3) divided by the drying time, ∆t, taken from 
initiation of primary drying to the sudden rise in temperature reported by the 
thermocouple (Figure 1). The temperature difference between Ts and Tp is the average, 
(𝑇! − 𝑇!), over this time period (Eqn 7). Once the Kv for each vial has been accurately 
determined, the ice sublimation rate at each time point can be calculated from Eqn 6. 
 









Determination of P0: 
In addition to 𝑚, the calculation of Rp from Equation 7 requires the vapor 
pressure of ice at the sublimation interface P0, which is an exponential function of the 
product temperature at the same location T0 (Eqn 9). 
 
 𝑃! = 2.69×10!"𝑒(!!"##.!" !!) Eqn 9 
The product temperature at the sublimation front T0 can be found from the temperature at 
the vial bottom measured by thermocouple, Tp. In this work, we described a simplified 
calculation (Eqn 11) from Eqn 2 in Tang et al. 2. The heat transferred from the shelf to the 
bottom of product (Eqn 5) approximately 1 equals to the heat flow from the bottom of the 
product through the thickness of ice to the ice sublimation interface (Eqn 10). 
 
 𝑞 = 𝐴!
𝑘!"#
𝑙!"#
𝑇! − 𝑇!  
Eqn 10 
The temperature at the sublimation interface, T0, is obtained by combination and 
rearrangement of Eqn 5 and 10, (Eqn 11), which depends on the vial heat transfer 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  In Eqn 5, the heat transfer comes from all sources including the top and the bottom of the shelf to the vial, reflected in Kv. In Eqn 10, 
the heat transfer driven by ∆T (Tp-T0) only comes from the bottom shelf to the sublimation interface over a thickness of Lice. The 
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coefficient (Kv), the thermal conductivity of ice (kice), thickness of ice (Lice), and Tp. Kv is 
found from Eqn 8 as described in the previous section. The value of kice is 5.9×10-3 
cal·cm-1·K-1·s-1 11. The calculation of Lice as a function of time is described through Eqns 
12 to 14. 
 
𝑇! = 𝑇! −
𝐿!!"𝐾!  (𝑇! − 𝑇!)
𝐾!"#
 Eqn 11 
As ice undergoes sublimation, the thickness of the remaining ice, 𝐿!"# , decreases 
and the thickness of the “dried” porous layer of solute over the sublimation interface, 
𝐿!"#, increases. The thickness of the “dried” layer, 𝐿!"#,!  , at a given time is related to the 
initial thickness of the frozen layer, 𝐿!"#, and the amount of water lost up to that time 






 Eqn 12 
Lice and Ldry are related (Eqn 13). 
 
 𝐿!"# = 𝐿!"# − 𝐿!"# Eqn 13 
𝐿!"# is the initial height of the frozen sample. In the case of high concentration 
amorphous solute in the solution, the frozen sample consists of the frozen ice and the 
unfrozen amorphous material, and 𝐿!"# can be calculated (Eqn 14), 
 
 










) Eqn 14 
where 𝑉!"## and 𝜌!"#$ represent the fill volume and density of the solution, respectively.  𝜌! 
and 𝜌! represents the density of ice and the unfrozen amorphous material.   
Approximately, ½ of the unfrozen water originally presented in the freeze-concentrate is 
lost during primary drying. This amount of unfrozen water lost due to early secondary 
drying is <1% of the frozen water in the case of 2mL of 10% sucrose solution, and the 
influence of early secondary drying on water loss is negligible. 
 
The amount of ice sublimed at each of several time intervals can also be calculated (Eqn 
15). 
 
∆𝑚! =   
(𝑚!! +𝑚!!!!)
2 𝑡!!!−𝑡!  
Eqn 15 
 
The cumulative amount of ice sublimed at each time, 𝑀!, equals the sum of the 
differential amounts of ice sublimed ∆𝑚! within each time interval, Δ𝑡 (Eqn 16). The 
calculation is valid until the thermocouple loses contact with ice at the bottom of the vial, 





 Eqn 16 
If sublimation occurs with radial and angular symmetry and no significant 
secondary drying takes place, the value of 𝑀! at the end of primary drying should be 
equal to the theoretical amount of water lost to sublimation, 𝑚!!!(Equation 3).   
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 In summary, the calculation of product resistance in individual vials, at each time, 
Rp (t) using the “direct vial” method was achieved from the determination of 𝑚(𝑡) and 
P0, both of which depends on accurate determination of Kv for that vial These 
calculations were carried out with an MS Excel spreadsheet, which will be made 
available to interested parties.   
 
Determination of Rp in vials at various shelf locations by establishing “Rp - SSA” or 
“Rp – ice nucleation temperature” correlation 
The ice nucleation temperature largely determines the porous structure in the 
dried layer, therefore the resistance to mass flow (Rp) 12,13. A higher ice nucleation 
temperature yields larger ice crystals and therefore lowers SSA of the freeze-dried 
sample. Thus, in principle, one can estimate the Rp of a particular group of vials (i.e., 
edge vial vs. center vial), if the ice nucleation temperature or SSAs are known. 
Previously, linear correlations between Rp and SSA were established in various 
formulations including sucrose, mannitol, dextran and hydroxyethyl starch 1. The 
correlation in the sucrose samples was based on a 5 mL fill of 5% sucrose solution in 20 
mL vials, where the average Rp was calculated over a cake thickness of 1 cm. In the 
present work, 2 mL of 10% sucrose solution was filled in 10 mL vials with a fill depth 
0.6 cm. Therefore, the correlation established in Rambhatla et al., can not be directly used 
to estimate a true Rp in samples at a different concentration and fill depth.  
In this study, we established similar correlations using the 10% sucrose samples. 
Rp in a given vial was calculated using the “direct vial” method. There were challenges in 
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determining Rp in edge vials (discussed in Section 3 of Results and Discussion). Rp in 
center vials were calculated over an Ldry of 0.60 cm (explained in “Attempt to calculate 
Rp in edge and center vials” of Results and Discussion), and correlated with the measured 
SSA and ice nucleation temperature in corresponding vials. Further, the established linear 
correlation was used to estimate Rp in edge vials with known ice nucleation temperature 
or SSA. 90% confidence intervals (CI) for the linear regressions were constructed to find 
the uncertainty of the estimated Rp values for a given edge vial. 
 
Results and Discussion 
1. Distribution of ice nucleation temperature in a batch 
When ice nucleation was controlled at shelf temperatures of -5 and -8°C, ice 
nucleated at the highest temperature in the sucrose solutions on the left edge of the shelf, 
followed by the right edge; the solution in the center vials had the lowest ice nucleation 
temperatures (Table 1). This was caused by small temperature differences in the product 
at fixed nominal shelf temperature. In the absence of an ice nucleation control 
technology, ice nucleates spontaneously with an average ice nucleation temperature here 
of -12°C for solutions in vials at all three locations (i.e., center, left edge and right edge) 
on the shelf (Figure 2). The surface of the shelf near the outlet for heat transfer fluid, 
which located at the front left corner, had a slightly higher temperature (0.5°C) than near 
the inlet at the front right corner throughout the freezing steps. Interestingly, the 
temperature of the left side of the band was substantially higher (3°C) than the right side 
of the band at the time of ice nucleation.  The band temperature is controlled by the 
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temperature of the product, inner wall, and the shelf 14. Although the temperature of the 
inner wall may not be particularly sensitive to the temperature of the outer wall, the 
observed higher ice nucleation temperature on the left edge was perhaps due in part to 
higher radiation effect from the wall, behind which the electrical supply may provide 
additional heat relative to the right-hand wall of the dryer chamber.  
 
2. Correlation between the ice nucleation temperature and specific surface area (SSA) 
Smaller ice crystals are formed at lower ice nucleation temperatures, resulting in 
higher SSA in the freeze-dried cake 13. The SSA of the sucrose cakes lyophilized from 
10% sucrose solutions linearly correlated with ice nucleation temperature of the solution 
(R2=0.92), with higher SSA at lower ice nucleation temperature (Figure 3). Moreover, 
there was a shelf position dependence of the SSA. For example, at a nominal shelf 
temperature of -5°C, the ice nucleation temperature of the solutions in vials on the left 
edge was significantly higher than those on the right edge (-2.0 ± 0.6°C vs. -4.0 ± 0.0°C). 
Correspondingly, the SSA of the dried cakes from vials located on the left edge was 
smaller than on the right edge (0.29 ± 0.01 m2/g vs. 0.38 ± 0.00 m2/g). In addition, the 
SSA of the cakes in vials at the right edge was comparable to those in the center vials, 
corresponding to the similar ice nucleation temperatures (-4.1 ± 0.0°C vs. 4.0 ± 0.0°C) 
when nucleated at a shelf temperature of -5°C. The trend was similar when ice nucleation 
was controlled at a shelf temperature of -8°C (Table 2). Based on the correlation between 
ice nucleation temperature and SSA, one may expect the product resistance to be lower 
when ice nucleates at a higher temperature, due to the formation of larger ice crystals. If 
the correlation between Rp with either SSA or ice nucleation temperature is established, 
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one may be able to estimate Rp in a given vial with known SSA or ice nucleation 
temperature (discussed in the following section).   
 
3. Attempt to calculate Rp for edge and center vials 
The calculation of Rp in a given vial relies on accurate determination of Kv 
(discussed in “determination of Kv” in the Methods). Three methods were used for 
determining Kv including the standard gravimetric method with pure ice or the sample 
solution, and the “direct vial” method.  
Using the “direct vial” method, the assumption was made that all frozen water 
was sublimed when the thermocouple loses contact with ice and there was a sudden 
temperature rise (Figure 1). Kv was calculated from 𝑚  (Eqn 8), where ∆t (Eqn 2) was 
obtained from the start of primary drying to the time at which there was a sudden rise in 
temperature. However, in some vials, there was multiple “sudden rise” in temperature 
(Figure 1), making it difficult to unequivocally determine the drying time, ∆t. 
Additionally, we note that while the contour of the vial bottom can influence Kv values 
due to the contribution of gas conduction in the space between the shelf surface and the 
bottom of the vial, in this case vials were marked so that the same vials were used in the 
same positions for the Kv determination using all three methods.  
In addition to using the standard method to check the Kv determined by the “direct 
vial” method, a modification of the standard method was explored; values of Kv were 
determined gravimetrically according to the standard method protocol, except using the 
solution of interest, 10% (w/v) sucrose, in lieu of pure water. The freeze-drying process 
was manually stopped after 5 hours into primary drying, corresponding to 20-33% water 
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loss. As in the standard method, the vials were weighed before and after drying to 
measure 𝑚, which was used to calculate a Kv for each vial. The edge vial Kv values 
determined by this modification of the standard method were larger than when using the 
pure water gravimetric method but smaller than the “direct vial” method (Table 1).  
All methods provided comparable Kv values for the center vials. However, 
compared to the “standard” gravimetric method for determining Kv using pure ice (Table 
1), the Kv for the edge vials, particularly the left edge vial, calculated by the “direct vial” 
method was seriously overestimated using the cycle data (Eqn 2 and 8), probably because 
there was still some ice in the vials and the ∆t was too small. The “direct vial” method 
has been used successfully in our lab to determine Rp in center vials. Since the Kv values 
of the edge vials determined from the “direct vial” method were unrealistically large, the 
corresponding Rp will be unrealistic. To determine Rp in edge vials, an alternative 
approach was proposed and explained in the following section.  
 
4. Estimation of Rp in edge vials from “Rp - SSA” or “Rp – ice nucleation temperature” 
correlation using center vials 
Since the Kv values in the center vials were comparable in the three methods 
(Table 1), Rp calculated in those center vials using the “direct vial” method was assumed 
to be valid. Using these Rp values, linear correlations were established between Rp and 
ice nucleation temperature (n=30, R2=0.77, Figure 4) as well as Rp and SSA (n=10, 
R2=0.62, Figure 5). There is a good agreement in the estimated edge vial Rp values using 
either correlation (Table 2). Indeed, the cakes in vials located on the left edge of the shelf 
had the lowest Rp relative to the cakes in vials on the right edge and in center vials (Table 
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3), which is not unexpected. Analysis on 90% confidence interval for the prediction line 
showed significant lower Rp on the left edge due to a higher ice nucleation temperature 
(or lower SSA) compared to the center vial. Comparable Rp values were found in samples 
on the right edge and the center of the shelf.  The maximum difference in Rp was found to 
be 26% between the left edge and center vials in the case when ice nucleation was 
controlled at -5°C. Estimation of Rp in the edge vials from the correlation established 
from Rp (calculated from the center vials) and the ice nucleation temperature or SSA 
provides good information on shelf location-dependence of Rp. The extrapolation of Rp in 
edge vial was based on the assumption that the samples on the edge dry in a similar 
manner as the center vial. In cases of high solid content with high fill depth undergoing 
aggressive drying conditions, the ice morphology and drying behavior can be very 
different between the center and edge vials. Rp may also be affected by other factors such 
as gaps (i.e. shrinkage) between the glass vial and the sample, which is not reflected in 
SSA and ice nucleation temperature. 
The data suggested Rp is lower in the edge vials due to a higher ice nucleation 
temperature. It should be noted that the results in the present study may not be widely 
generalizable to other freezing process; the observations were based on controlled ice 
nucleation cycles using Lyostar freeze-dryers, at relatively high shelf temperatures (i.e. -5 
and -8°C). Cautions are needed when controlling ice nucleation at a higher shelf 
temperature; the temperature of the sample solutions should be monitored since thermal 
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Summary  
It is commonly accepted that controlled ice nucleation results in homogeneous ice 
nucleation temperature across a batch. However, in the present study, a distribution of ice 
nucleation temperatures was found within batches where ice nucleation was controlled.  
Even though nucleation was synchronized, the solutions in vials at the left edge of a 
laboratory freeze-dryer underwent ice nucleation at a higher temperature than in vials at 
the right edge and center of the shelf. SSA of the cakes in the vials followed the opposite 
rank order as the ice nucleation temperature for the three locations of vials.  
Without the technology available to monitor ice sublimation rate from a single 
vial in a batch without disrupting the heat flow pattern in the freeze-dryer, there is no 
direct experimental method for determining any corresponding rank order of Rp with 
position.  A “direct vial” method of calculating Rp from cycle data proved to be a 
challenge due to difficulties in accurately assessing individual vial Kv values for the edge 
vials, particularly vials on the left edge. However, the calculated Kv values in center vials 
are comparable with the values determined using the standard gravimetric method. 
Correlations were established between Rp, SSA and ice nucleation temperature using the 
center vials, and further were used to estimate Rp in edge vials. Left edge vials with 
higher ice nucleation temperatures showed lowest Rp to sublimation followed by 
comparable Rp in the right edge vials and center vials. Thus, even with synchronous ice 
nucleation also called controlled nucleation, there may be differences in the resistance to 
sublimation, Rp, within a batch due to location-dependence of heat transfer during the 
freezing step. Note that the “edge vial effect” on Rp is opposite to the “edge vial effect” 
on Kv.   
 




Table 1. Kv ×104 (cal·cm-2·K-1·s-1) values determined from three methods. Ice nucleation 
temperature was controlled at -5°C. Primary drying was performed at a shelf temperature 
of -30°C and chamber pressure of 60 mTorr. The values were represented as average ± 
standard error of the measurements (n=4 for the left and right edge vials, n=8 for the 
center vials). 
Vial location “Direct vial 
method”  
Gravimetric method 
(with 10% sucrose)  
Standard gravimetric 
method (with pure ice)  
Left edge 9.9 ± 0.9 6.78 ± 0.9 5.7 ± 0.2 
Right edge 6.5 ± 0.6 5.95 ± 1.4 5.3 ± 0.3 
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Table 2. Estimated Rp (cm2 · Torr · hr ·g-1) in each group of vial at various locations of the 





(Avg ± Std) 
SSA (m2/g) 
(Avg ± Std) 





90% CI From  
Rp-SSA 
90% CI 
Controlled ice nucleation at a shelf temperature of  -5°C 
Left edge -2.0 ± 0.6 0.29 ± 0.01 3.5 ± 0.3 3.0 – 4.0 3.3 ± 0.3 2.7 – 3.9 
Right edge -4.1 ± 0.0 0.38 ± 0.00 4.4 ± 0.2 4.0 – 4.8 4.5 ± 0.1 4.2 – 4.7 
Center -4.1 ± 0.4 0.39 ± 0.00 4.4 ± 0.2 4.1 – 4.8 4.6 ± 0.1 4.3 – 4.9 
Controlled ice nucleation at a shelf temperature of  -8°C 
Left edge -5.3 ± 0.0  0.43 ± 0.01 5.1 ± 0.2 4.8 – 5.4 5.1± 0.1 4.9 – 5.4 
Right edge -7.1 ± 0.4 0.47 ± 0.00 5.9 ± 0.2 5.6 – 6.2 5.6± 0.2 5.3 – 5.9 
Center -6.8 ± 0.6 0.45 ± 0.02 6.0 ± 0.2 5.7 – 6.3 5.4± 0.1 5.1 – 5.6 
* The estimated Rp values were presented as the estimated values from the correlation 


















Figure 1. An example of product temperature and chamber pressure profile of 10% (w/v) 
sucrose; ice nucleation was controlled at a shelf temperature of -5°C. On the top panel, 
the red and blue curve represents the pressure in the chamber measured by the Pirani 
gauge and capacitance manometer (CM), respectively. The curves on lower panel 
represent the shelf temperature set point and temperature traces of the samples measured 
by thermocouple placed in the bottom center of the vial. The arrows show the time points 
when the thermocouple lost contact with ice. Often times, multiple “sudden temperature 













Figure 2. Distribution of ice nucleation temperature across a batch under three conditions: 
uncontrolled ice nucleation (UCN), controlled ice nucleation at shelf temperatures of -5 




















Figure 3. Specific surface area (SSA) of 10% (w/v) sucrose as a function of ice 

















Figure 4. Correlation between calculated Rp in center vials and the corresponding ice 
nucleation temperature. The data (n=30, with black symbols) were fitted in a linear 
function (black line) to estimate Rp in edge vials. 90% confidence interval for the 















Figure 5. Correlation between calculated Rp in center vials and the corresponding SSA 
measured by BET. The data (n=10 since only 10 measurement of SSA were available,) 
were fitted in a linear function (black line) to estimate Rp in edge vials. 90% confidence 
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Chapter 5 
Protein Internal Dynamics Associated with Pre-Tg Endothermic Events: 
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Abstract 
Lyophilized proteins are generally stored below their glass transition temperature 
(Tg) to maintain long-term stability. Some proteins in the (pure) solid state showed a 
distinct endotherm at a temperature well below the glass transition, designated as a pre-Tg 
endotherm.  The pre-Tg endothermic event has been linked with a transition in protein 
internal mobility. The aim of this study was to investigate the internal dynamics of two 
proteins, insulin and human growth hormone (hGH), both of which exhibit the pre-Tg 
endothermic event with onsets at 50-60°C. Solid-state hydrogen/deuterium (ss-H/D) 
exchange of both proteins was characterized by Fourier Transform Infrared (FTIR) 
spectroscopy over a temperature range from 30 to 80°C. A distinct sigmoidal transition in 
the extent of H/D exchange had a midpoint of 56.1 ± 1.2 °C for insulin and 61.7 ± 0.9°C 
for hGH, suggesting a transition to greater mobility in the protein molecules at these 
temperatures. The data support the hypothesis that the pre-Tg event is related to a 
transition in internal protein mobility associated with the protein dynamical temperature. 
Exceeding the protein dynamical temperature is expected to activate protein internal 
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b	  dT: ¼ width of the sigmoidal transition; k: apparent rate constant of the observable H/D exchange; Tmid: temperature midpoint of the 
sigmoidal transition; X: fraction of H/D unexchanged protons on protein molecule; X0: the fraction at time zero; X∞: the fraction at the 
apparent plateau level; X∞i: X∞ initial value ; X∞f: X∞ final value	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Introduction 
        Freeze-drying has been widely used to minimize potential chemical and physical 
degradation of proteins by the conversion of a protein solution into amorphous (or at least 
partially amorphous) solid material.  In order to achieve optimal long-term stability, it is 
recommended that freeze-dried proteins should be stored well below the glass transition 
temperature (Tg) of the entire system (i.e., an assembly of protein molecules or protein 
molecules dispersed in a matrix) 1-4.  The Tg of such a molecularly miscible system marks 
the onset temperature of viscous flow with higher mobility on a large length-scale, 
reflecting the movement and collisions between protein molecules or protein molecules 
with the excipient matrix.   However, there is an increasing body of work demonstrating 
that physical and/or chemical degradations still occur during storage at temperatures 
below the system Tg 5-7.  Besides the global glass transition temperature for the system, 
the concept of a glass transition temperature within an individual protein molecule, 
known as the protein dynamical temperature (Td), was introduced to describe local 
fluctuations of protein residues on a smaller length-scale.  As the protein temperature 
increases beyond the “protein dynamical temperature”, the protein molecule experiences 
larger fluctuations in structure on shorter time scales, (which is analogous to a small 
molecule glass passing through it’s Tg), eventually resulting cooperative changes 
producing significant mobility on the short time scale of the differential scanning 
calorimetry (DSC) scan.  The protein dynamical temperature (Td) within protein molecule 
has been well studied in systems with high water/polyol content and in sugar/water glassy 
matrices 8-10, but little experimental work has been done in dry proteins.  At temperatures 
exceeding the protein dynamical temperature, the increase in local internal motions of 
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protein molecule may have significant stability implications in solid protein 
formulations11.  
        In amorphous systems consisting of small molecules, the system Tg can be measured 
by DSC. The glass transition temperature is observed as a sharp shift in the DSC 
thermogram, due to an increase in heat capacity (ΔCp).  This increase in heat capacity is 
often accompanied by a non-reversing endotherm, associated with enthalpy recovery 12.  
In contrast, the glass transition temperature of pure proteins cannot be detected by DSC, 
because a pure protein behaves as a strong glass (i.e., characterized by a broad glass 
transition with a small change in Cp at Tg) 13.  However, at least in principle, the enthalpy 
recovery endotherm should still be observable, which is the suspected origin of a pre-Tg 
endotherm in solid pure proteins.  Pre-Tg endothermic events were reported for both 
crystalline and amorphous insulin 14, lyophilized human growth hormone (hGH) 15, and 
bovine serum albumin (BSA) 16.  These endotherms occur well below the global Tg for 
solid pure proteins, which is around 150°C 13,16.   The temperature marking the onset of 
mobility within BSA, as determined by H/D exchange, coincided with the temperature of 
the pre-Tg endotherm; this supports the concept that the pre-Tg endotherm represents 
enthalpy recovery corresponding to the “molecular glass transition” within the protein 
molecule, or “protein dynamical temperature” 16.  It should be noted that pre-Tg thermal 
events have also been reported for non-protein systems during DSC scans 12,17.  However, 
such an endothermic event in those glassy systems was explained by a very broad 
distribution of enthalpy relaxation times caused by the variation of thermal history and 
mobility during processing.  The pre-Tg endothermic event in pure protein, such as BSA, 
has a higher activation energy (138 kJ/mol) 16 than the pre-Tg events in non-protein 
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glassy systems (75 kJ/mol or less in unannealed samples) 18,19.  In this work, we continue 
the investigation of the pre-Tg endothermic event in two additional proteins, hGH and 
insulin, following essentially the same H/D exchange procedure as previously described 
16. 
Materials and Methods 
Materials 
        Insulin and hGH samples were provided by Eli Lilly & Co (Indianapolis, IN).  Pure 
insulin was in the form of crystalline recombinant insulin.  Recombinant human growth 
hormone (hGH) was pure amorphous freeze-dried material, without excipient.  
Deuterium oxide (99.8 %D), lithium chloride (>99%, ACS grade), and potassium 
bromide (99%, IR grade) were purchased from Acros Organics (Morris Plains, NJ).  
Methods 
        Procedures were essentially equivalent to those previously described 16 and are 
briefly summarized here. 
H/D exchange process 
        Pure insulin or hGH was transferred to glass desiccators where 11% RH was 
maintained by saturating D2O with LiCl 20.  The desiccators were sealed under vacuum 
and stored at temperatures ranging from 30 to 80°C.  Previous experience with such 
vacuum “humidity chambers” indicates mass transfer equilibrium is established within 
10-20 hours for such samples. The samples were removed at 1, 2, 3 and 4 days under dry 
air atmosphere and dried immediately in a vacuum oven (model 281A, Fisher Scientific, 
Pittsburgh, PA) at room temperature and “full vacuum” for 24 hours, so as to quench the 
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H/D exchange reaction. Quenched samples were analyzed by FTIR spectroscopy. All 
measurements were performed in duplicate.  
FTIR measurement 
        Samples of 0.5-0.8 mg of insulin or hGH were gently ground with 150 mg of dried 
potassium bromide (KBr) in a glove bag purged with dry air.  The resulting mixture was 
compressed at 10,000 psi for 2 minutes using a laboratory press (Carver Inc, Wabash, 
IN).  The compressed pellet was transferred to a sample holder in a FTIR spectrometer 
(Nicolet Magma 560, Thermo Scientific, Madison, WI).  The CO2 level and water vapor 
in the spectrometer chamber were controlled by a purging system with moisture and CO2 
traps (Puregas, LLC, Broomfield, CO).  
        Spectra were recorded in single beam mode with 128 scans and 4 cm-1 resolution 
over a range of 400-4000 cm-1.   All spectra were processed using software provided with 
the FTIR spectrometer (Grams/AI 8.0, Thermo Electron, Madison, WI).   Each spectrum 
was first converted to the absorbance format by subtracting the background spectrum 
collected with KBr.  The residual water vapor signals, if any, were removed by 
subtracting the spectrum of gaseous water until a smooth spectrum was obtained in the 
2000-1800 cm-1 range 21.  The amide I band with maximum absorbance at around 1658 
cm-1 consists of primarily C=O stretching modes, and is not influenced by H/D exchange 
22.  Therefore, the intensity of the amide I band in each spectrum was used to normalize 
the absorbance for direct comparison among spectra.  
Data Analysis 
        The extent of H/D exchange was calculated as previously described (Equations 4-6; 
16).   The equations are listed in the caption of figure 4 and 5. Briefly, the fraction of 
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protons remaining to be exchanged, X, was evaluated over 4 days in duplicate studies for 
each protein.  Each set of X versus time data were fitted by a first order decay function to 
find X∞ and its error.  An average of the duplicate values of X∞ was calculated, along 
with the associated error determined by propagation of errors.  The value of X∞ at each 
temperature with its error was fitted by a sigmoidal function to find the temperature 
midpoint of the transition and its associated error.   
Results and Discussion 
Observation of the pre-Tg endothermic event 
        The glass transition temperature, Tg, of pure proteins can be determined by 
extrapolating the Tg of systems containing protein co-lyophilized with disaccharide to 
100% protein using the Fox equation.  Using this extrapolation, the system glass 
transition of pure hGH in solid state was determined to occur at 136°C (Table 1), which 
is below the denaturation temperature (above 150°C) at which large-scale molecular 
mobility on the DSC scan timescale is required 13.  Another endothermic signal in a DSC 
warming scan was also observed for both hGH and insulin, at a temperature well below 
the system Tg (Table 1) 14,15.  In Figure 1, the DSC thermogram labeled 4.1 (meaning the 
water content was 4.1%) represents hGH equilibrated at 11% RH, where a small broad 
endotherm occurs with an onset of ≈50°C and a maximum at 60°C (Figure 1). Similarly, 
the DSC thermogram of insulin at 11% RH shows an endothermic event with an onset of 
≈50°C and a maximum at 70°C (Figure 2).           
        The pre-Tg endothermic events for both proteins disappeared on rescanning and 
hence are not reversible on the timescale of DSC scan. This is a characteristic of enthalpy 
recovery signal superimposed on a system glass transition.  However, the glass transition 
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temperature is much higher than the pre-Tg endotherm. Instead, the pre-Tg endotherms 
could be the relaxation enthalpy within the protein molecule recovered at the temperature 
associated with a transition in protein internal mobility as has previously been suggested 
16.  While the glass transition temperature of the protein molecule, or “dynamical 
temperature” may be reversible, the accompanying change in mobility is not directly 
detectible by DSC.  However, when the protein is held/stored for a long time at a 
temperature below the Td, enthalpy relaxation 12 within the protein would be recovered on 
scanning through the Td.  Without a long hold time post first scan, the pre-Tg 
endothermic events disappeared at the second scan during the time scale of the DSC 
experiments, which is much shorter than that of the enthalpy relaxation.  It is well known 
that protein molecules demonstrate glass-like properties (i.e., KWW non-exponential 
relaxation) associated with diffusive mobility; it has been argued that fast local non-
diffusive movement of the amino acid residues within proteins lead to side chain rotation 
and segmental fluctuations 5,11,23-25.  These β-like processes collectively give rise to 
highly cooperative “α-mobility”-related event, responsible for protein internal mobility 
11.  The activation energy of the pre-Tg thermal event in BSA was found to be 138 kJ/mol 
16, which is more characteristic of “α-mobility” than of fast β or γ-mobility (~ 50 kJ/mol) 
16,26.  Therefore, the pre-Tg endothermic events, having similar characteristics with 
system glass transition, would be associated with α-like motion, which is activated at this 
temperature range.   
       The broad pre-Tg endotherm became more energetic and moved slightly towards 
lower temperatures with increasing water content (Figure 1).  Samples were equilibrated 
with a range of relative humidities for the same time period.  At higher water contents, 
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enthalpy relaxation would be faster, ultimately resulting in a greater enthalpy recovery, 
near the onset of the glass transition of the protein molecule.  The shifting to lower 
temperatures is qualitatively similar to the plasticizing effect of water on the system glass 
transition.  It was suggested that water facilitates the propagation of β-like motion within 
the protein molecule into α-like motion that is responsible for protein dynamical 
transition at Td 11.  Protein denaturation generally requires large-scale motion involving 
the entire peptide backbone.  Thus, the observation that the water content appears to have 
a larger effect on protein denaturation and Tg than on the pre-Tg event (presumably the 
Td) suggests that the pre-Tg event was due to a transition in protein internal mobility at a 
smaller length scale compared to the system glass transition and protein denaturation.   
Investigation of protein internal dynamics by ss-H/D exchange study  
        The function of proteins depends on their well-defined three-dimensional structure 
and the ability to rearrange its structure in order to respond to the environment such as 
association/dissociation processes.  This adaptability, reflecting protein intrinsic 
flexibility and dynamics is strongly affected by many factors including temperature and 
hydration 27.  As protein internal mobility increases, some amide hydrogens initially 
buried in the interior of the protein molecule become transiently exposed and accessible 
to D2O due to this dynamic or breathing motion of protein molecules, resulting in 
enhanced H/D exchange 28.  The rate and extent of H/D exchange also reflects the time-
average conformation of the protein (i.e., where the exchangeable hydrogens are, on 
average, located).  Therefore, H/D exchange can be a measure of both dynamics and 
“structure” in the protein molecule, both of which are relevant to stability.  Mass 
spectroscopy, nuclear magnetic resonance (NMR) and FTIR spectroscopy have been used 
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to monitor the extent of H/D exchange in protein molecules 28-32.  The degree of 
exchanges at specific locations in the primary structure of solid proteins can be measured 
by employing LC-Mass spectroscopy 33.  In this work, FTIR was used to monitor the 
extent of H/D exchange, because it is a simpler and faster technique, providing 
essentially the same information on non-site specific, total exchange with time. 
        Changes in the FTIR spectra of hGH and insulin equilibrated with D2O vapor as a 
function of temperature are shown in Figure 3.  The amide II’ band at 1445 cm-1 
corresponds to N-D vibrations developed upon H/D exchange, and the peak intensity 
increases as the reaction proceeds.  However, there is an additional contribution to the 
amide II’ signal from H-O-D vibration in partially deuterated water3.  Similarly, the 
amide II band at 1535 cm-1 represents the N-H vibrational mode, the peak intensity of 
which decreases as hydrogen is replaced by deuterium.  However, this amide II band does 
not contain interfering contributions from absorption bands of H-O-H, H-O-D and D-O-
D.  The shoulder around 1515 cm-1 is a characteristic band of the tyrosine aromatic ring 
vibration, and is not sensitive to the H/D exchange reaction 34,35.  In an attempt to resolve 
the signal at 1535 cm-1 from overlapping signals, primarily from tyrosine ring vibration, 
deconvolution of the individual peaks in the range of 1300-2000 cm-1 was attempted.  
However, the necessary assumption of Gaussian peak shape introduced artificial peaks in 
some spectra, resulting in more uncertainty in the measurement of the area of the 
deconvoluted peak than in the height of the peak at 1535 cm-1.   The contribution of 
tyrosine vibration to the intensity at 1535 cm-1 was found to be less than 0.5% and 3% for 
hGH and insulin, respectively.  Therefore, the intensity of the amide II band at 1535 cm-1 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3	  Exhibits strong absorbance around 1460 cm-1 32.	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was used to monitor the extent of H/D exchange as a function of time and temperature, as 
in the previous study 16.  The peak intensity decreased with temperature, indicating 
enhanced H/D exchange at elevated temperatures (Figure 3). 
        The fraction of hydrogens remaining un-exchanged was estimated from the ratio of 
relative peak intensity of the amide II band at any time point to that at time zero 16.  The 
time course of H/D exchange was approximated as a single first order exponential decay 
(Figure 4), to a final fraction of hydrogens remaining un-exchanged, X∞.  H/D exchange 
kinetics are expected to follow at least double exponential decay, representing fast 
exchange for the “exposed” protons and slow exchange for the “buried” protons.  The 
mass transfer equilibrium is essentially complete after about 24 hours at room 
temperature. The actual H/D exchange rate with the protein is not confounded by the 
mass transfer kinetics after one day.  Instead. over the 4 day duration of our experiments, 
the rate constant for exchange of the “buried” protons is expected to be so slow that the 
fraction of unexchanged protons, X, appears to approach a constant at long times, X∞, 
representing the fraction of “buried” protons.  The value of X∞ was obtained by 
regression analysis using Equation 5 of Mizuno and Pikal 16.  Others have used the rate 
constant of the H/D exchange process to differentiate protein dynamics in a series of 
formulations 33.  In the present work, the exchange of available hydrogens occurred too 
rapidly (i.e., within one or two days) (Figure 4) to accurately evaluate a rate constant.  
Moreover, any time constant would likely represent a combination of mass transfer 
kinetics and H/D exchange kinetics.  The unexchanged hydrogens, represented by X∞, 
are presumably buried in the interior of the protein folded structure where they are not 
dynamically accessible by the D2O vapor on the time scale of the experiment 16.  Thus, 
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the final extent of H/D exchange, X∞, should quantitatively provide information on the 
temperature dependence of protein dynamics.   
        A sigmoidal function was fitted to the temperature dependence of the plateau level 
of ss-H/D exchange (i.e., X∞) for hGH and insulin (Figure 4).  The mid-point of the sharp 
decrease in X∞ obtained from the sigmoidal function fell in the same temperature range 
as the DSC pre-Tg transitions 14,15.  For hGH, the mid-point of this transition in protein 
dynamics was at 61.7 ± 0.9°C compared to the pre-Tg endothermic event at 50-70°C with 
a maximum at 60°C.  Similarly, the mid-point of the protein internal dynamical transition 
for insulin, by H/D exchange, was found to occur at 56.1 ± 1.2°C, corresponding to the 
broad pre-Tg event in DSC between 50-80°C with a maximum at 70°C.  In BSA, the low 
temperature pre-Tg DSC endothermic event was suggested to result from a mobility 
transition within the protein molecule itself, since it occurred over the same temperature 
range as the sharp increase in extent of H/D exchange 16.  Alternatively, it could be 
argued that the pre-Tg endotherm and the temperature dependence of the H/D exchange 
correspond to a protein conformational change, such as a partial unfolding.  However, at 
least from the FTIR spectra, there were no detectable changes in secondary structure with 
insulin or hGH, although a tertiary structural change, such as a transition to a “molten 
globule” state cannot be ruled out from the available data.  Whether the temperature 
dependence of H/D exchange is attributed to a transition in internal protein dynamics or 
to a conformational change may not affect its implications for protein stability.  Just as 
the glass transition results in a state of higher entropy relative to the structure below Tg, 
the protein structure above the protein molecule’s glass transition (dynamical transition) 
would likely be a structure of higher entropy, as well as a state of greater configurational 
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mobility.  For example, if the protein transitions to a “molten globule” type of structure, 
both the time-average tertiary structure would change (i.e., partially lost) and the protein 
internal mobility would increase, both of which have potentially adverse stability 
consequences.  In summary, the H/D exchange data suggest that there is a transition in 
protein mobility, which is the origin of the pre-Tg endothermic events detected by DSC.  
Both the DSC endotherm and the H/D exchange transition result from collective small-
scale motions within the protein molecules, which increase at the protein dynamical 
temperature.  
Stability consequences of protein internal dynamics   
        Solid protein formulations are normally stored at a temperature, T, well below Tg to 
improve stability during storage.  However, often there is no correlation between protein 
stability and the temperature difference, T-Tg, at storage temperatures well below Tg 6. 
Proteins in solution, in membranes and in crystalline states lose function at or near the 
protein dynamical temperature (Td) 36.  Therefore, more recently, it has been argued that 
protein formulations should be stored below the dynamical temperature, Td, representing 
the temperature at which protein molecules gain internal mobility 5.  
        The protein dynamical temperature Td can be modulated through dehydration and 
lyoprotectants 9-11,27,37,38.  For example, analysis of the fluctuation in the internal structure 
of hydrated proteins suggested that changes within the hydration layer, which are coupled 
to the protein, determine the protein dynamical temperature Td 39,40.  Additionally, studies 
of the kinetics of ligand binding of carbon monoxymyoglobin in a dry trehalose system 
demonstrated that glassy trehalose suppressed the inter-conversion of protein 
conformational substates in the protein molecule, meaning that protein internal motion 
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became limited or locked in the more rigid trehalose matrix 41.   Based on these findings, 
Hill and co-workers suggested that there is a network of hydrogen bonding that connects 
the protein surface with water and the disaccharide (such as sucrose and trehalose); the 
composition of the dried product including residual moisture plays an important role in 
coupling protein internal dynamics with that of the surrounding matrix 5.   Therefore, 
effective coupling between protein internal dynamics and the dynamics of the matrices 
(potentially evaluated by H/D exchange) should be significant in predicting the long-term 
stability of protein pharmaceuticals in the solid state.  Recently we have started one study 
on formulated recombinant human serum albumin. 
Conclusion 
        Solid-state hydrogen/deuterium (ss-H/D) exchange monitored by FTIR spectroscopy 
can provide a useful tool to investigate the dynamical transition in protein molecules.  
The current study extends the set of data using this method to two additional proteins, 
insulin and hGH.  Data and previous interpretations suggest that such studies may well 
play an important role in quickly predicting differences in storage stability in a series of 
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TABLES 
Table 1. Summary of transition temperatures of hGH, insulin and BSA as a function of 
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a Obtained  from 15 except where noted. 
b Obtained from 14 except where noted. 
c Obtained from 16 except where noted. 
d Temperature midpoint of the thermal events. 
e Obtained from 13. 













Figure 1.  DSC thermograms for freeze-dried hGH as a function of water content, 
indicated for each sample in weight percent.  The solid samples were hermetically sealed 
and scanned at 10°C/min from 20 to 180°C. N.B.  On re-scanning from room temperature 
past the end of the pre-Tg endotherm (about 90°C), but well below either the estimated 
system Tg or the denaturation temperature, the endothermic event was not detectible. 









Figure 2.  DSC thermograms of amorphous (solid line) and crystalline (dashed line) 
insulin equilibrated at 11% RH and 75% RH.  The solid samples were hermetically 
sealed and scanned at 10°C/min from 20 to 180°C. N.B.  On re-scanning from room 
temperature past the end of the pre-Tg endotherm (about 90°C), but well below either the 
estimated system Tg or the denaturation temperature, the endothermic event was not 









Figure 3.  Selected FTIR spectra of pure hGH (a) and insulin (b) recorded from 30 to 
80°C during the H/D exchange process.  The amide I band was normalized for 
comparison among spectra.  The intensity decay of the amide II band representing N-H 













Figure 4.  First order decay plot of the ratio of un-exchanged hydrogen (X) at various 
temperatures for pure hGH (a) and insulin (b) equilibrated in D2O at 11% RH.  The first 
order kinetics of the reaction was quantitatively analyzed by non-linear curve fitting 
using the following exponential model: (𝑋 = 𝑋! + 𝑋! − 𝑋! exp  (−𝑘𝑡)), where t is 
time, k is an apparent rate constant for the observable exchange, X∞ and X0 are H/D un-












Figure 5.  Temperature dependence of the plateau level of H/D exchange (X∞) in pure 
hGH (a) and insulin (b), fitted to a sigmoidal function: 
𝑋! = (X!! − X!!) (1+ 𝑒𝑥𝑝 ((𝑇 − 𝑇!"#) 𝑑𝑇)+ X!!, where X∞i, X∞f, Tmid, dT are X∞ 
initial value, X∞ final value, temperature midpoint of the sigmoidal transition, and ¼ 
width of the transition, respectively.  The mid-point of the sharp transition (Tmid) in pure 
hGH was 61.7 ± 0.9°C, with dT 6.3 ± 1.0°C. The mid-point of the sharp transition (Tmid) 
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Chapter 6 
Apparent Protein Internal Dynamics: Investigation of its Implication on Protein 
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Abstract 
Recent hydrogen/deuterium (H/D) exchange studies suggest that a structural 
and/or mobility transition in the protein molecule in the solid state, similar to the protein 
dynamical temperature (Td), exists in a temperature range below the system glass 
transition temperature (Tg). If this transition does indeed represent a protein dynamical 
temperature in the solid state, one might expect protein stability in the solid to correlate 
with the difference between storage temperature and this apparent Td. Solid-state H/D 
exchange in conjunction with FTIR spectroscopy was used to study this transition in both 
pure proteins and proteins formulated with disaccharides, and further to evaluate whether 
this apparent Td of the protein molecule can be modulated by coupling with the inert 
matrix.  The hypothesis is that the formulation that provides effective coupling of Td with 
the dynamics of the matrix should demonstrate better long-term stability in the solid state. 
That is, a formulation with a higher Td should show better stability. In this work, we 
study the impact of formulation on Td in recombinant human serum albumin (rHSA) and 
on stability in freeze-dried sucrose and trehalose formulations. We find rHSA:sucrose 
showed superior long-term stability at 40°C by size exclusion chromatography (SEC) 
than the trehalose formulation, but the apparent Td was much higher in the trehalose 
formulation. Both sucrose and trehalose showed equivalent protection of protein 
secondary structure by FTIR spectroscopy. On the other hand, a lower extent of H/D 
exchange (X∞) was observed in the sucrose formulation at the temperature of the stability 
studies (40°C) than found for the trehalose formulation, which was consistent with better 
stability in the sucrose formulation. Thus, while apparent Td did not correlate with protein 
stability for rHSA, the extent of H/D exchange, X∞ did.  
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Introduction 
Freeze-drying is commonly used to improve the stability of proteins, which 
undergo significant physical and/or chemical degradation in solution. In order to achieve 
optimal long-term stability, it is recommended that freeze-dried solid proteins should be 
stored below the glass transition temperature (Tg) of the entire system (i.e., an assembly 
of protein molecules or protein molecules dispersed in a matrix). The Tg of such a 
molecularly miscible system marks the onset temperature of viscous flow with higher 
mobility on a large time scale (i.e. 10-104 s). However, there is an increasing body of 
work demonstrating that physical and/or chemical degradations still occur during storage 
at temperatures well below the system Tg 1-3. Moreover, there is no correlation between 
protein stability and Tg at temperatures well below Tg 4.  
Previous studies on pure solid bovine serum albumin (BSA) 5, insulin and human 
growth hormone (hGH) 6 suggested onset of significant mobility in the protein molecule 
at temperatures below the system Tg. This mobility was suggested to represent protein 
internal dynamics, which implies that the temperature at which this transition occurs 
represents the protein dynamical temperature, Td, in the dry solid state. The low 
temperature motion arising from the protein molecule was suggested to be associated 
with local fluctuations of protein residues on a smaller time scale (i.e. 10-15-10-1 s) 1. 
Thus, at temperatures exceeding the protein dynamical temperature, there is an increase 
in local internal motions, which eventually result in larger cooperative motions, and 
therefore may affect stability of the protein formulations. Evidence of loss in protein 
function at Td has also been reported 7-9. Td was well studied in systems with high 
water/polyol content and in sugar/water glassy matrices, but very little work in dry 
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proteins 10-12. The potential stability implication of the protein dynamical temperature in 
solid protein formulations of pharmaceutical significance has been recently emphasized 
13.  
The Td can be modulated through the degree of hydration and addition of 
lyoprotectant 11-16. Hill and co-workers suggested that it is the hydrogen bonding 
interactions between water and the amino acid residues that facilitates the propagation of 
fast β-like motions into larger scale α-like motions, which are responsible for protein 
internal dynamics. Studies on the kinetics of ligand binding to carbon monoxymyoglobin 
in a dry trehalose system demonstrated that the glassy trehalose suppressed the inter-
conversion of protein conformation sub-states, suggesting that protein internal motion is 
limited or locked in the relatively more rigid matrix 17. Therefore, effective coupling 
between protein internal dynamics and the dynamics of the matrices may play an 
important role in the stability of protein pharmaceuticals.  
Hydrogen deuterium (H/D) exchange has been employed extensively to gain a 
better understanding of protein structural features and conformational dynamics 18-22. The 
rate and extent of H/D exchange can provide a measurement of protein structure and/or 
dynamics in the protein formulation, which are relevant to stability. Solid-state H/D 
exchange in conjunction with FTIR was applied previously to study the apparent protein 
dynamical transition as signaled by the sharp transition in H/D exchange over a small 
temperature range 5,6. In the present study, we applied the same approach and extended 
the study on protein internal dynamics to proteins formulated with lyoprotectants. 
Recombinant human serum albumin (rHSA) was used as the model protein. Sucrose and 
trehalose were chosen as the lyoprotectants since both are commonly used to stabilize 
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proteins in the solid state. The ultimate goal was to address the question whether or not 
the best stability during storage would be the formulation in which the apparent Td is 
higher.   
Materials and Methods 
Materials and sample preparation 
Stock solution of ultrapure rHSA (50 mg/mL, Albumin Bioscience, Huntsville, 
AL) was dialyzed using a 10K MWCO dialysis cassette against 5 mM potassium 
phosphate buffer (pH 7.0) at 4°C twice for 3 hours and the third time overnight. The 
recovered solution was filtered through 0.22 µm polyvinylidene difluoride (PVDF) low 
protein binding filter (33mm in diameter). The concentration of rHSA after dialysis was 
determined by absorbance at 280 nm (Cary Bio100, Varian Inc., Palo Alto, CA) using 
extinction coefficient of 0.58 mL/mg-cm 23. Sucrose or trehalose (Sigma Aldrich, St. 
Louis, MO) was added to the formulation at 1:1 weight ratio of disaccharide to protein. 
The protein was formulated at 3 mg/mL in all three formulations. 
D2O (99.8% D), lithium chloride (LiCl) (>99%, American Chemical Society 
grade), and potassium bromide (KBr; 99%, infrared grade) from Acros Organics (Morris 
Plains, NJ) were used for the H/D exchange study.  
 
Freeze-drying procedure 
Aliquots of one mL of each sample solution were filled in 5 mL glass tubing vials 
and were partially stoppered with Daikyo Fluorotec stoppers (West Pharmaceutical 
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Services, West Whiteland, PA) to minimize moisture transfer during storage. All vials 
containing the samples were placed on the center of the shelf surrounded by 5% (w/w) 
sucrose solutions to avoid any radiation effect from the edge and front of the chamber 
and maintain comparable product temperatures. Product temperature was monitored with 
a thermocouple glued with heat sink silicone grease (Chemplex 1381, FUCHS lubricants, 
Harvey, IL) and Kapton tape (Cole-Parmer, Vernon Hills, IL) to the outside of selected 
vials near the vial bottom. The samples were freeze-dried according to the recipe (Table 
1) and then stoppered, sealed and stored in the -20°C freezer for further analysis.  
 
Physical stability of rHSA formulations during storage by SEC 
Freeze-dried rHSA samples were equilibrated at 11% RH overnight and stored at 
40°C for 6 months. The samples after each time point (0, 1, 3, 6 month) were 
reconstituted with 1 mL of water (18 MΩ, distilled and deionized, Barnstead™ 
GenPure™, Thermo Scientific, Waltham, MA). No precipitation or visible particle was 
observed after reconstitution. The entire volume of reconstituted solutions was filtered 
with 0.22 µm PVDF filters and 50 microliters of each sample were injected onto a 
column (TSKgelTM G3000SWXL, 7.8 mm x 30 cm, 5 µm, Tosoh Bioscience, San 
Francisco, CA) maintained at 25°C. The mobile phase (100 mM sodium phosphate buffer 
with 0.2 M NaCl at pH 7.0) was delivered at 1.0 mL/min by an HPLC system (Model 
1100, Agilent, Santa Clara, CA). The absorbance of the effluent was measured at 280nm 
(variable wavelength detector, G1315A, Agilent). Absorbance data were acquired and 
analyzed (ChemStation, Agilent). Monomer, dimer, and higher order aggregates were 
identified. Percent soluble aggregate represents the areas under the dimer and higher 
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order aggregate peaks relative to total area of the identified peaks.  
Protein aggregation follows the square root of time kinetics 2. Therefore, the rate 
constant of aggregation was determined by fitting the stability data in the equation below. 
                                 %  𝑃   = %  𝑃! + 𝑘√𝑡                                                      
%P, %P0, and k represent the present soluble aggregates at time t, time 0 (after freeze-
drying), and the rate constant of aggregation, respectively.  
Secondary structure of the rHSA formulations 
Spectra of the protein samples were recorded with a FTIR spectrometer (Nicolet 
Magma 560, Thermo Scientific, Madison, WI) in single beam mode with 128 scans and 4 
cm-1 resolution over a range of 400-4000 cm-1. All spectra were processed using the 
software Grams/AI 8.0 (Thermo Electron, Madison, WI). Secondary structure of the 
rHSA formulations was characterized from the amide I band in the region 1600-1700 cm-
1 of the FTIR spectra. This region primarily consists of C=O stretch mode, which is well 
known to be sensitive to protein secondary structure. Second derivative analysis of the 
amide I region was carried out to resolve the underlying peak components in this region. 
 
H/D exchange process to evaluate the dynamics of the protein formulations 
The solid-state H/D exchange process for the freeze-dried rHSA formulations 
followed the same procedure developed in previous studies 5,6. Briefly, the freeze-dried 
samples were incubated in a desiccator maintained with 11% RH using saturated LiCl 
solution in D2O. The desiccators were sealed under vacuum and stored at various 
temperatures from 30 to 80°C. The H/D exchange reaction was quenched by drying the 
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samples in the vacuum oven at room temperature overnight. The time course (over 4 
days) of the H/D exchange process at each temperature was determined from FTIR 
measurement. All measurements were performed in duplicate. 
 0.6 mg of each freeze-dried protein sample was mixed with 150 mg of KBr in a 
glove bag where humidity was controlled below 2% by purging dry air. Spectra of the 
protein samples were recorded with a FTIR spectrometer. The extent of H/D exchange 
was based on the intensity change of the amide II peak at 1535 cm-1, which represents N-
H vibration mode. The calculation was based on studies as previously described 5,6. 
 
Data analysis on the H/D exchange process 
 Regression analysis was performed in the H/D exchange process using the same 
approach employed in a previous study 6. Briefly, the fraction of protons remaining to be 
exchanged, X, versus time was evaluated over 4 days in each formulation and fitted by a 
first-order decay function as previously described 6 to find X∞ (the “plateau un-
exchanged fraction” of hydrogens on the protein) and its error. The value of X∞ at each 
temperature with its error was fitted by a sigmoidal function 6 to find the temperature 
midpoint of the transition (inflection point) and its associated error. 
 
Results and Discussion 
Aggregation stability of the freeze-dried rHSA formulations during storage  
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To evaluate any possible correlation between the protein apparent dynamical 
temperature (Td) and the protein stability in the solid state, sucrose or trehalose with 
distinct glass transition temperatures were added to the rHSA formulation. Physical 
degradation, specifically formation of soluble aggregates of the rHSA formulations were 
compared during storage at 40°C and 11% RH. Protein aggregation followed square root 
of time kinetics. The rate constant for protein aggregation, k (% ∙𝑚𝑜𝑛𝑡ℎ𝑠!!/!), was 
determined from the slope of the linear fit (Figure 1). As expected, rHSA alone was least 
stable with a rate constant of 12.5% ∙𝑚𝑜𝑛𝑡ℎ𝑠!!/!. Both disaccharides stabilized rHSA 
reducing the rate constants to 3.6 and 1.2% ∙𝑚𝑜𝑛𝑡ℎ𝑠!!/! for trehalose and sucrose, 
respectively (Figure 1).  
 
The effect of sucrose and trehalose on stabilizing protein formulations during freeze-
drying 
Both sucrose and trehalose are known to stabilize protein formulations after 
freeze-drying 4. The “water substitute hypothesis” describes stabilization by the 
disaccharide through hydrogen bond formation with the protein molecule, whereas the 
“glass dynamics hypothesis” explains stabilization through reduced mobility in the rigid 
matrix 4. The addition of sucrose to a protein formulation results in a decrease in Tg 
compared to protein alone 2,24,25 which is contrary to its stabilizing effect based on the 
simple interpretation of the “glass dynamics hypothesis”, which suggests that the system 
with the higher Tg will be more stable. The stabilization effect by sucrose is not 
necessarily in conflict with a more general interpretation of the impact of glass dynamics 
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on stability 2. It is possible that rather than the system Tg, the protein dynamical 
temperature (Td) may be a more appropriate measurement to determine stability, which 
can be modulated by the excipients.  
Better solid-state stability in a sucrose formulation compared to a trehalose 
formulation was also reported for IgG, hGH and lysozyme (Table 2). It was suggested 
that lower amplitude motions associated with “fast dynamics” in the hGH:sucrose 
formulation (on a nanosecond scale) as measured by neutron scattering correlated with 
the better stability compared to trehalose 2. Micro-phase separation of trehalose 
formulations was another proposed mechanism of the lower stability in trehalose than in 
sucrose 13.  In contrast, sucrose and trehalose formulations provided comparable solid-
state stability of catalase, interlukin-2, and a recombinant humanized monoclonal 
antibody (rhu-mAb) when stored at a temperature below the glass transition temperature 
of the formulation (Table 2). However, better solid-state stability in trehalose than in 
sucrose was found in hGH and a mAb when stored at a condition that the glass transition 
temperature of the sucrose formulation was below or equal to the storage temperature 
(Table 2).  
 
Secondary structure of the rHSA formulations 
 Protein aggregation often requires protein structural perturbation. The 
rHSA:sucrose formulation showed superior physical stability during long-term storage 
than the trehalose formulation (Figure 1). To evaluate whether the difference in 
aggregation is associated with conformational stability (i.e. protein structure) between the 
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two formulations after freeze-drying, the secondary structure of the freeze-dried samples 
was characterized using the second derivative of the amide I region in the FTIR spectra. 
rHSA consists of predominantly α-helix in its secondary structure (1654 cm-1). Both the 
sucrose and trehalose formulations protected rHSA from severe perturbation in secondary 
structure due to the freeze-drying process, in the sense that a much sharper α-helix peak 
with higher intensity was evident in the disaccharide formulations compared to rHSA 
alone (Figure 2).  However, there were no differences in key features of the native α-helix 
band such as peak position or intensity of the sucrose and trehalose formulations. 
Similarly, in freeze-dried hGH:dissachride 1:6 (w:w), where the aggregation rate constant 
was about a factor of two less in the sucrose formulation than in the trehalose formulation 
2, there was no difference in their secondary structure by FTIR spectroscopy. Although 
there was no difference in secondary structure within the sensitivity of the FTIR 
spectrometer, it is possible that minor tertiary structural alteration may exist that cannot 
be captured by FTIR spectroscopy.  
Investigation of protein dynamical temperature using H/D exchange   
In previous studies, low-temperature endothermic events (40~60°C) below the Tg 
of the protein were observed in differential scanning calorimetry (DSC) in solid pure 
BSA, insulin and hGH without excipients 5,6,26. It was proposed that the endotherms 
potentially represented enthalpy recovery of a protein dynamical transition within the 
protein molecule. The temperature of the enthalpy recovery correlated well with a 
transition temperature found using H/D exchange monitored by FTIR, supporting the 
suggestion that the low temperature endotherms were associated with a protein dynamical 
transition temperature.  
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Based on extensive literature on the protein dynamical transition in hydrated 
systems1, Hill, Shalaev and Zografi hypothesized that effective coupling between the 
internal dynamics within the protein molecule and a stabilizer could provide better the 
long-term stability of the formulation. However, no experimental studies have tested this 
hypothesis in the solid state. To explore the impact of this transition on protein stability in 
solid state, we evaluated Td of the three formulations, rHSA alone, rHSA:sucrose 1:1 
(w:w) and rHSA:trehalose 1:1 (w:w). Pre-Tg events were previously reported in 
hGH:disaccharide formulations 26; however, the events were attributed to the 
disaccharide itself, which has a pre-Tg signal in the same temperature range, due to a 
distribution of relaxation times within the non-equilibrium amorphous solid system. 
Therefore, a pre-Tg endothermic event in the protein molecule, could not be uniquely 
identified from the DSC scan, at least when the protein formulation contains sucrose or 
trehalose. However, any change in the protein mobility/structure with temperature, which 
can be monitored by the H/D exchange at the amide nitrogen would be not be 
complicated by the presence of a stabilizer such as sucrose or trehalose, at least in theory.  
 In the present study, a change in the mobility of the protein was monitored by the 
extent of H/D exchange, not on the rate of H/D exchange.  The rate of H/D exchange 
would potentially be complicated by the presence of the stabilizer.  The extent of H/D 
exchange on the protein molecule was based on the intensity change of the amide II peak 
at 1535 cm-1, which presents N-H stretch mode. The absorption spectra of sucrose and 
trehalose were in the range of 1400 to 400 cm-1 (C-O stretch), and above 3200 cm-1 (O-H 
stretch); neither overlapped with the protein amide II. To further evaluate any 
interference of sucrose and trehalose with FTIR monitoring of H/D exchange, the 
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spectrum of freeze-dried amorphous sucrose was subtracted from the spectrum of 
rHSA:sucrose. The intensity of Amide I band was used for normalization.  The analytical 
peak (amide II at 1535 cm-1) was unaffected by subtraction of the sucrose spectrum 
(Figure 3). Similarly, trehalose did not affect the amide II band (data not shown). 
Therefore, all analysis was performed using the spectral data without subtraction of the 
stabilizer spectra, following a previously established methodology 5,6.   
Freeze-dried rHSA samples with or without stabilizer were equilibrated with 11% 
RH D2O over a range of temperature. Samples were taken each day for 4 days to 
determine the equilibrium extent of H/D exchange. High variability in the preliminary 
data was observed for the pure rHSA  (3 mg/mL) samples taken from the same or 
different vials. Some of the variations may have come from inter-vial variation in ice 
nucleation temperature, leading to inter-vial variation in protein structure as reported 
elsewhere 27. The high variation was not observed in the sucrose or trehalose formulation.  
Therefore, to reduce the variation in the pure rHSA sample, a higher concentration of 
pure protein, (i.e., 25 mg/mL compared to 3 mg/mL in the presence of stabilizers) was 
freeze-dried such that all pure protein samples used for the H/D exchange were taken 
from the same vial (well mixed) to ensure uniformity in structure in the pure protein 
samples.  
The H/D exchange was monitored in the FTIR spectra as a function of 
temperature. Since H/D exchange can be a measure of both protein structure and 
dynamics, a greater extent of exchange is expected at a higher temperature when the 
interior of the protein molecule is exposed to the D2O vapor, and/or when there is greater 
fluctuation in protein molecular structure (i.e., faster dynamics). The amide II band at 
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1445 cm-1 represents the N-D vibrational mode. However, the contribution from H-O-D 
vibration mode at 1460 cm-1 interferes with this signal 22. Instead, the amide II band at 
1535 cm-1, representing the N-H vibrational mode, was used to monitor the extent of H/D 
exchange. The amide I band at 1655 cm-1, which is not influenced by the H/D exchange 
process was used for normalization of the spectra.  At higher temperatures, the intensity 
of amide II band at 1535 cm-1 decreased, suggesting enhanced H/D exchange due to 
perturbation in protein structure or increase in mobility within the protein molecule 
(Figure 4).  
The fraction of hydrogens remaining un-exchanged (denoted as X) at any time is 
the ratio of the intensity of amide II (1535 cm-1) relative to its intensity before exchange. 
The time course of the H/D exchange process was treated empirically as a first-order 
exponential decay (Figure 5). The extent of exchange at infinite time (X∞), was 
determined from the regression analysis using Equation 5 of Mizuno and Pikal 5.  The 
amide hydrogens remaining unexchanged (X∞) were not dynamically accessible by the 
D2O vapor on the time scale (4 days) of the experiment, as they are presumably buried in 
the “rigid” interior of the protein-folded structure. Thus, the goal was to use the X∞ 
versus temperature to quantitatively interpret the temperature dependence of protein 
dynamics. 
As in previous studies 5,6, a sigmoidal function was fitted to the temperature 
dependence of X∞. The mid-point of the transition (Tmid), nominally equivalent to the 
dynamical transition temperature (Td) of the protein molecule, was obtained from the 
sigmoidal function (Figure 6).  According to the hypothesis of Hill, Shalaev and Zografi, 
the formulation that yields a higher Td of the protein would be effectively coupled to the 
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protein and provide better stabilization. The transition region for X∞ with temperature for 
pure rHSA was broad ±6 °C (compared to the previously reported transition in insulin 
and hGH 6) with a midpoint, or nominally Td of 56 °C (Figure 6). The transition in Td in 
rHSA:sucrose was at 62.3°C (±3.3°C), higher than that of pure rHSA. This observation 
was qualitatively consistent with the well-known stabilizing effect of sucrose. However, 
the X∞ versus temperature for rHSA:trehalose was not sigmoid in shape within the 
temperature range from 30 to 100°C. Perhaps the Td of rHSA:trehalose is above this 
temperature range, beyond what was experimentally accessible, due to the use of the 11% 
RH chamber. However, if the protein in trehalose does have an inflection point associated 
with a Td or other relevant transition, it is clearly higher than when the protein is 
formulated with sucrose. 
If the hypothesis on protein dynamical temperature (Td) were true, the trehalose 
formulation would be expected to be more stable than the sucrose formulation owing to 
the presumably higher Td of the protein in trehalose. However, clearly the rHSA:sucrose 
formulation was more stable than the trehalose formulation with a degradation rate 
constant only 1/3 that of the trehalose formulation (Figure 1). The stability data in the 
present study is not consistent with the hypothesis that trehalose should provide better 
stability due to a higher Td. Perhaps Td is not a predictive parameter for stability in the 
rHSA system. Further studies with other protein systems formulated with other excipients 
that lead to distinct Td values are needed to fully understand this Td concept, particularly 
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The extent of H/D exchange 
Neither apparent Td, nor the secondary structure correlated with stability of 
rHSA:disaccharide formulations during storage. The extent of H/D exchange (X∞), which 
provides another measure of structure or dynamics in the protein formulation was 
compared between the sucrose and trehalose formulation, which was used in recent H/D 
exchange studies 28,29. There was a trend of lower extent of H/D exchange in the 
rHSA:sucrose formulation at 40°C, suggesting better stability in the sucrose formulation 
(Figure 7) at the stability storage temperature of 40°C. At temperatures above 60°C, the 
trend was reversed with less H/D exchange in the trehalose formulation, likely because 
the temperature was reaching the glass transition region for the sucrose formulation but 
not the trehalose formulation. We note that sucrose:hGH (1:1) at 11% RH has a Tg of 
58°C, but the corresponding trehalose formulation has a Tg of 70°C.  Thus, the extent of 
H/D exchange in the formulation at the lower temperature of 40°C seemed to predict 
protein stability. Both sucrose and trehalose are well known as very good lyoprotectants 
in protein formulations, providing essentially identical stability results in some cases and 
a modest increase in stability in the sucrose formulation for several cases, including hGH 
2, IgG 25 and rHSA. H/D exchange seems to have sufficient sensitivity to predict such 
modest changes in stability. Recently, Moorthy and colleagues demonstrated strong 
correlation between the deuterium incorporation at time 0 using H/D exchange-mass 
spectrometry (HDX-MS) and the extent of aggregation during storage in myoglobin 28 
and monoclonal antibody 29 formulated with excipients with stabilization propensities 
very distinctive from each other (i.e. sucrose, mannitol, NaCl). Our results are consistent 
with theirs but with systems with much smaller stability differences. Previously, fast 
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dynamics by neutron scattering correlated with the stability difference between the 
sucrose and trehalose formulations in hGH 2. Potentially these methods, H/D exchange 
and “fast dynamics” can be used to capture small differences in proteins formulated with 
similar stabilization effects, and therefore to predict modest protein stability differences 
in the solid state. 
 
Summary and Conclusions 
We have observed what appears to be a protein dynamical temperature (Td) 1,13 in 
solid state proteins below the system glass transition temperature 5,6, which means a 
cooperative transition in mobility within the protein molecule. Solid-state H/D exchange 
in conjunction with FTIR spectroscopy was used to study this phenomena in both pure 
proteins and proteins formulated with disaccharides, and further to evaluate whether the 
apparent Td of the protein molecule can be modulated through coupling with the inert 
matrix (sucrose or trehalose). A higher Td should mean a more stable protein formulation. 
However, rHSA:sucrose showed superior long-term stability at 40°C by SEC than the 
trehalose formulation but exhibited a lower apparent Td. Further, while both sucrose and 
trehalose showed equivalent protection of protein secondary structure by FTIR 
spectroscopy, the extent of exchange at nominal time infinity, (X∞) was less for sucrose 
than for the trehalose formulation at 40°C, suggesting that at least at 40°C, the protein 
structure and/or dynamics was more native/rigid in the sucrose formulation.  Although 
the apparent Td did not correlated with protein stability in rHSA systems, the extent of 
H/D exchange did correlate, suggesting X∞ can potentially be a useful predictor in 
stability of the freeze-dried protein during storage, consistent with data in the literature 
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28,29. Further studies with other protein systems formulated with excipients that lead to 
distinct Td values are needed to fully understand the where or not the apparent Td is 
indeed a protein dynamical temperature in the solid state, and if in other systems, this 






















Table 1. Freeze-drying recipe 
Step Freezing Primary drying Secondary drying 
Temperature (°C) 5 -5 -40 -30 40 
Ramp rate (°C/min) 1 1 1 0.5 0.2 
Hold time (min) 30 30 180 * 120 
Vacuum (mTorr) - - - 60 60 
* The process was advanced to secondary drying when the Pirani gauge signal converged 






















Table 2. Comparison of stability of proteins formulated with sucrose or trehalose. 








50°C, 22% RH 
NA 
Sucrose > trehalose 
Sucrose < trehalose a 









40°C, 11% RH 
Sucrose > trehalose 









Sucrose ≈ trehalose  















Sucrose ≈ trehalose 
Sucrose < trehalose b 
Sucrose ≈ trehalose 





* rhu-MAb represents recombinant humanized monoclonal antibody 
a Tg of the sucrose and trehalose formulations were 36°C and 50°C, respectively, when 
stored at 50°C, 22% RH. 
b Tg of the sucrose and trehalose formulations were 59°C and 80°C, respectively, when 


















Figure 1. % Soluble aggregation by SEC in the three formulations, rHSA (circle), 
rHSA:sucrose 1:1 (w:w) (triangle), and rHSA:trehalose 1:1 (w:w) (square). The samples 
were equilibrated with 11% RH and then stored at 40°C for 6 month. Error bar represents 















Figure 2. Second derivative of amide I region in the FTIR spectra of the three 
formulations after freeze-drying. This process allows the underlying components that 
overlap in the amide I region to be visually resolved. rHSA consists of predominantly α-
helix structure with a peak at 1654 cm-1. The remaining structural elements are β-sheet 
and random turns. rHSA was formulated at 3 mg/mL in three formulations: rHSA alone, 














Figure 3. FTIR absorption spectra of freeze-dried rHSA:sucrose formulation before (solid 
line) and after subtraction of the sucrose spectrum (dashed line). The intensity of amide I 
band (1655 cm-1) was normalized for comparison. The subtraction procedure did not 
affect the intensity of the amide II band at 1535 cm-1, which was further used to calculate 



















Figure 4. Representative FTIR spectra of freeze-dried rHSA (left), rHSA:sucrose 
(middle) and rHSA:trehalose (right) recorded from 30 to 90°C after 4 days of the H/D 
exchange process.  The amide I band was used to normalize the spectra.  The decay in 
peak intensity of the amide II band (1535 cm-1) representing N-H vibrational modes was 
monitored to determine the extent of the H/D exchange reaction. 
 
 
















Figure 5. First order decay plot of the ratio of un-exchanged hydrogens (X) at various 
temperatures for rHSA (left), rHSA:sucrose (middle) and rHSA:trehalose (right) 
equilibrated in D2O at 11% RH.  The first order kinetics of the reaction was quantitatively 
analyzed by non-linear curve fitting using the following exponential model: (𝑋 = 𝑋! +
𝑋! − 𝑋! exp  (−𝑘𝑡)), where t is time, k is an apparent rate constant for the observable 
exchange, X∞ and X0 are H/D un-exchanged fractions at the apparent plateau level (i.e., 


















Figure 6. Temperature dependence of the plateau level of H/D exchange (X∞) in pure 
rHSA (left), rHSA:sucrose (middle) and rHSA:trehalose (right), fitted to a sigmoidal 
function: 𝑋! = (X!! − X!!) (1+ 𝑒𝑥𝑝 ((𝑇 − 𝑇!"#) 𝑑𝑇)+ X!!, where X∞i, X∞f, Tmid, 
dT are X∞ initial value, X∞ final value, temperature midpoint of the sigmoidal transition, 
and ¼ width of the transition, respectively.  The mid-point of the sharp transition (Tmid) in 
pure rHSA was 56.2 ± 6.3°C. The mid-point of the transition (Tmid) in the rHSA:sucrose 
formulation was, 62.3 ± 3.3°C. No sigmoidal transition was found in the rHSA:trehalose 














Figure 7.  Fraction of un-exchanged hydrogens at infinite time (X∞) at selected 
temperatures for the two formulations, rHSA:sucrose and rHSA:trehalose. Error bars 
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  Lyophilization is a commonly used approach to improve stability of 
pharmaceutical proteins when they are not sufficiently stable in solution due to physical 
or chemical degradation. However, there are several challenges in the design of freeze-
drying process and formulation approaches inhibiting the ability to deliver final products 
with uniformly improved stability in an efficient manner. These challenges include the 
natural variation in ice nucleation temperature, lack of understanding of the critical 
factors for protein stability after the ice nucleation step, as well as the potential role of 
protein internal dynamics on stability of proteins formulated with excipients. The goal of 
this work was to understand how the freeze-dried protein quality attributes could be 
affected by these stress factors. 
Work presented in Chapter 2 and 3 investigated how the freezing protocols can 
affect protein stability during freeze-drying. Large variations exist in ice nucleation 
temperature across the batch. A lower ice nucleation temperature results in smaller ice 
crystal size, and hence larger surface area between the growing ice and the freeze-
concentrate where proteins can adsorb and denature. Moreover, the variation in ice 
nucleation temperature can result in heterogeneity in protein stability. Few controlled ice 
nucleation reports have focused on protein stability. In Chapter 2, a focused study was 
performed on the effect of controlling ice nucleation temperature on stability of a model 
protein known to be sensitive to the ice surface, lactate dehydrogenase (LDH), 
formulated without any stabilizer. Both average stability of LDH within a batch and 
homogeneity in stability were evaluated when the samples were frozen at various 
controlled ice nucleation temperatures as compared to the freezing condition without ice 
nucleation control. This study provides direct evidence of improved protein stability 
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during freeze-thawing when ice nucleation was controlled at a higher temperature. This 
work provides the first report that demonstrates improved batch uniformity in protein 
stability using the controlled ice nucleation technology, ControLyo™.  
Very little information is available on controlled nucleation’s effect on the 
stability of proteins formulated with excipients. Chapter 3 extended the study of ice 
nucleation temperature in proteins formulated with excipients. Two model proteins were 
used in the study including intravenous immunoglobulin (IVIG) and recombinant human 
serum albumin (rHSA) and were formulated with or without the presence of a stabilizer, 
sucrose. The degree of improvement in protein stability when controlling ice nucleation 
at a higher temperature appeared to be protein-dependent. The second part of the 
investigation in Chapter 3 was to understand the critical factors attributed to protein 
stability post ice nucleation. Two opposing effects (ice surface area and residence time in 
the freeze-concentration) were proposed to affect protein aggregation. The shelf ramp 
rate and isothermal hold were varied after ice nucleation while maintaining the same ice 
nucleation temperature. Although the theory has been discussed previously, this study 
provided experimental evidence in supporting the residence time in the mobile, more 
freeze-concentrated environment as an important factor in protein aggregation post ice 
nucleation. The results are directly relevant to process design in bulk freezing and 
thawing when the freezing time is much longer. In addition to stability, characteristics of 
the final solid including morphology and porous structure were characterized at various 
freezing conditions using the polymer encapsulation method, mercury intrusion 
porosimetry method and specific surface area measurements. The findings suggest that it 
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is not only the ice nucleation temperature, but also the thermal history post ice nucleation 
that define the surface area of ice and the porous structure of the freeze-dried cake. 
Further, a distribution in ice nucleation temperature within a batch was observed 
even when ice nucleation was controlled at a fixed time and shelf temperature. Based on 
this observation, Chapter 4 attempted to address whether there is a shelf location-
dependent resistance to mass flow (Rp) during primary drying, due to the distribution in 
ice nucleation temperature. In existing literature, the resistance to mass flow during 
primary drying, product resistance (Rp) was determined as a batch average. The first step 
was to calculate Rp in individual vials. The calculation using cycle data was described 
and challenges in using this method were addressed. Finally, correlations were 
established between ice nucleation temperature, specific surface area (SSA), and Rp in 
center vials (in which the calculated Kv in the sample solution was found reliable). The 
correlations were further used to estimate Rp in samples placed at other locations of the 
shelf (i.e. edge vials). This study filled the gap in the area of understanding whether Rp is 
dependent on the location of the vial and provides insights in developing methods to 
accurately measure real-time Rp in individual vials.  
Endothermic events were previously reported in DSC scan in pure insulin and 
hGH in the solid state; the events occurred at temperatures well below the glass transition 
temperature of the system, referred to as pre-Tg. Chapter 5 discussed and studies the 
origin of the pre-Tg endothermic events. Enhanced internal motion on the protein 
molecule in that temperature range was hypothesized as the underlying cause of the pre-
Tg events. This phenomenon, protein internal dynamics, was studied by solid-state 
hydrogen/deuterium (H/D) exchange in conjunction with FTIR spectroscopy. The results 
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showed a sigmoidal transition in H/D exchange in the same temperature range as the pre-
Tg endothermic events. This work presented a new concept in dry proteins based on 
existing knowledge about the dynamics on the protein molecule well studied in systems 
with high water/polyol content and in sugar/water glassy matrices. 
Chapter 6 is a continued exploration on whether the protein internal dynamics 
studied in Chapter 5 has any stability consequence in protein formulations in the solid 
state. Soluble aggregation during storage was evaluated in rHSA freeze-dried with 
sucrose or trehalose. Solid-state H/D exchange with FTIR spectroscopy was used to 
determine the dynamical temperature (Td) in each formulation. It was found that rather 
than Td, the lower extent of H/D exchange in the sucrose formulation correlated with its 
better stability compared to the trehalose formulation. Further work using other proteins 
and/or excipients is needed to fully understand the implication of apparent Td on protein 
stability in the solid state.  
Significance 
With the correlation established between protein stability and ice nucleation temperature 
in the laboratory, the degradation of proteins in manufacturing arising from ice nucleation 
temperature differences can be quantitatively predicted. The capability of improving 
batch homogeneity by controlling uniform ice nucleation provides potential advantages in 
scaling-up from lab to manufacturing scale. Fundamental understanding of the 
degradation stresses during freezing, the implication of protein internal dynamics and 
interactions with the formulation matrix will provide information critical to the efficient 
formulation and process design.  
